Sequence Specific Alkylation of DNA by Polyamide-Chlorambucil Conjugates by Wurtz, Nicholas Roland
Sequence Specific Alkylation of DNA by 
Polyamide-Chlorambucil Conjugates 
Thesis by 
Nicholas R. Wurtz 
In Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosophy 
California Institute of Technology 
Pasadena, California 
2002 
(Submitted November 27,2001) 
© 2001 
Nicholas R. Wurtz 




I would like to thank my advisor, Professor Peter Dervan, for providing an exciting 
environment to do research. I would also like to thank the members of my committee, 
Professors Robert Grubbs, Steve Mayo, and David MacMillan. 
While in the Dervan group I have worked with a wonderful group of people. I have 
immensely enjoyed many conversations with Doan about science, careers and life in general 
and hope that they continue. Ryan taught me the "Dervan way" and became a good friend. 
Aileen is perhaps the nicest person that I have ever encountered and is also a patient 
instructor from whom I learned much. Jason Belitsky has a wonderful dry wit and can find 
a silver lining in most any lab result and will make a good professor someday. I enjoyed 
trading investment advice with Clay and admire his determination. Victor provided clever 
insight that made me smile on many occasions. Anna always provided good advice. I've 
enjoyed getting to know Phillip and his family in the past year. It was a pleasure to have 
another father in lab to laugh with about the exploits of our sons. It has been an honor to 
collaborate with Joel Pomerantz and Matt Porteus, who also had the patience to answer my 
many questions about biology. I have enjoyed sharing a lab with Ryan, Ulf, Eric, Shane and 
Nick. Thank you for putting up with my many messes. 
Most importantly, I would like to thank my family. I would not be here without the 
support of my parents. I contribute my healthy outlook on life to my wife and son, Heather 
and Alexander, both of whom I love dearly. They made me smile even after the most 
frustrating days in lab and helped me keep things in perspective. 1 am blessed to have such 
loving wife with whom to share my life. 
IV 
Abstract 
Small molecules that bind selectively to a DNA sequence in the human genome are 
potentially useful tools for molecular biology and human medicine. Polyamides containing 
N-methylimidazole (1m) and N-methylpyrrole (Py) are small molecules that bind DNA 
according to a set of "pairing rules" with affinities and specificities similar to many 
naturally occurring DNA binding proteins. Two alternate routes of synthesis of polyamides 
are presented that allowed improved synthesis of commonly used motifs as well as access to 
polyamides with truncated tails which increase the number of DNA sequences targetable by 
polyamides with high affinity. Py-Im polyamides may offer a general approach to chemical 
regulation of gene expression provided inhibition of DNA binding for a variety of 
transcription factor families can be achieved. Two successful strategies are shown for the 
inhibition of DNA binding by two such proteins, GCN4 and NF-KB. An alternate method 
of gene regulation would be inhibition of transcription during the elongation phase by site-
specific alkylation in the coding region of genes. A new class of compounds is created by 
the attachment of a bis (dichloroethylamino)-benzene nonspecific DNA alkylator to 
polyamides, which alkyl ate DNA with high yield and specificity. The biological activity and 
cell permeability of one of these compounds in several systems is studied. 
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The recent sequencing of the human genome has revealed that our genetic 
information is comprised of 3.2 gigabases of DNA organized into 30,000-40,000 protein-
coding genes (1, 2). It is now understood that nature controls the expression of each of 
these genes by a remarkable three-dimensional switch, that is composed of over 50 
proteins assembled on a few hundred specific base pairs of 'promoter' DNA sequence 
encoded upstream from the RNA polymerase start site and coding region. Each cell 
contains a copy of the individual's DNA that is essentially identical to that of every other 
cell, yet each cell has a specialized function that requires it to express certain genes while 
leaving others silent (3). Misregulation of gene expression resulting in aberrant 
biochemical behavior in cellular processes is responsible for numerous cancerous and 
viral disease states (4). Artificial ligands that can sequence specifically bind DNA and 
restore the natural patterns of gene expression would potentially be valuable tools in 
human medicine (5). 
DNA Recognition 
The double helix consists of the two strands of deoxyribose-phosphate polymers 
that display four heterocycles bases, adenine (A), thymidine (T), guanine (G), and 
cytosine (C), bound in anti-parallel orientation. In duplex DNA, the two strands are held 
together via Watson-Crick hydrogen bonding of A, T and G,C base pairs (6). The 
common .B-form of DNA is characterized by a wide (12 A) and shallow major groove 
and a narrow (4-6 A) and deep minor groove (Figure 1.1) (7). In addition, sequence-
dependent structural variations, conformational properties, and solvent and counterion 
Figure 1.1. CPK model (left) and ribbon representation (right) of B-form duplex DNA. The sugar 
phosphate backbone is shown in either blue or red. The base pairs are in yellow. (right) 
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organization can distinguish local DNA structures (7). Individual sequences may be 
distinguished by the pattern of hydrogen bond donors and acceptors, created by the base 
pairs. 
X-ray crystal and NMR structural analyses of naturally occurring protein-DNA 
complexes and natural products has provided insight into the design of novel DNA 
binding molecules (8, 9). Sequence-specificity arises from several methods of DNA 
interaction: specific hydrogen bonding or van der Waals contacts with functional groups 
in the grooves, Coulombic attraction to the negatively charged phosphodiester backbone 
or to the electrostatic potential in the grooves, and/or intercalation of aromatic functional 
groups between the DNA bases (10). In cells, nature has devised a combinatorial 








Figure 1.2. Representative X-ray crystal structures from a few families of DNA binding proteins. Proteins 
contact the DNA via interactions with the bases in the major groove and/or minor groove, as well as the 
sugar phosphate backbone. 
folded structures. DNA binding proteins adopt several structural motifs for sequence-
specific recognition including the zinc finger (11), the leucine zipper (12), and the helix-
tum-helix motifs (13) (Figure 1.2). Within these complexes, specificity for target sites is 
achieved through specific noncovalent interactions between the protein side chains and 
the nucleobases and phosphates of the DNA. However, no single motif exists that 
represents a general amino acid-base pair code for all DNA sequences (14). Although 
certain zinc finger-DNA complexes (15, 16) provide a versatile recognition code, the de 
novo design of proteins for DNA recognition remains challenging due to protein 
structural diversity and limitations in predicting protein folding. 
Small molecules isolated from natural sources are another class of DNA binding 
ligands that are structurally diverse, as evidenced by consideration of four representative 
molecules, chromomycin, distamycin, actinomycin D, and calicheamicin (Figure 1.3) 
(17-20). While these molecules can recognize short sequences of DNA through both 
intercalation between the bases and groove binding, there is no general recognition code 
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for the readout of specific sequences of DNA. Analogs of calicheamicin have been shown 
to bind DNA and interfere with transcription factor function; however, oligosaccharides 
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Figure 1.3. The structures of four small molecules isolated from natural sources. 
are not yet amenable to recognition of a broad range of predetermined DNA sequences 
(21, 22). Similarly, oligodeoxynucleotides which recognize the major groove of double 
helical DNA via triple helix formation bind a broad sequence repertoire with high affinity 
and specificity (23, 24). Although oligonucleotides and their analogs have been shown to 
interfere with gene expression, the triple helix approach is limited to purine tracks and 
suffers from poor cellular uptake (25, 26). 
DNA Recognition by Polyamides. 
Over the past two decades, the research efforts led by Prof. Peter B. Dervan of 
Caltech have resulted in a set of pairing rules to guide polyamide design for sequence-
specific recognition of DNA. A binary code has been developed to correlate DNA 
sequence with side-by-side pairings between pyrrole (Py), imidazole (1m), and 3-
6 
hydroxypyrrole (Hp) carboxamides in the DNA minor groove (Figure 1.4). A pairing of 
1m opposite Py (ImlPy) targets a G-e base pair, while Py/lm targets e-G. A Py/Py 
pairing is degenerate, targeting both A-T and T-A base pairs. An Hp opposite a Py 
(Hp/Py) discriminates T-A from A-T, while Py/Hp targets A-T in preference to T-A and 
both of these from G-e and e-G. Footprinting, NMR, and X-ray structure studies 
validate these pairing rules for DNA minor groove recognition (27, 28). 
5' 3' 
q Py/lm targets e-G 
q Py/Hp targets A-T 
q Py/Py targets A-T and T-A 
q Hp/Py targets T-A 
q Im/Py targets G-e 
Figure 1.4. A schematic representation of the polyamide pairing rules. 
The DNA-binding affinity and specificity of pyrrole-imidazole polyamides have 
been increased by covalently linking polyamide subunits. Polyamide dimers linked with a 
y-aminobutyric acid (y) tum residue provide a hairpin motif that binds target sites with 
two to three orders of magnitude enhanced affinity and has the important feature that ring 
pairings are unambiguously set in place as relative to homodimers which can afford 
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slipped motifs (29). Increasing the hairpin polyamide subunit lengths to four and five 
aromatic ring residues gives eight- and ten-ring hairpin polyamides with subnanomolar 
binding affinities, similar to naturally occurring DNA-binding proteins (30, 31). Studies 
of polyamide site size limitations suggest that beyond five consecutive rings, the ligand 
curvature fails to match the pitch of the DNA helix, disrupting the hydrogen bonds and 
van der Waals interactions responsible for specific polyamide-DNA complex formation 
(32). Addition of pairings with ~-alanine (~) to form ~/~, ~lPy, and ~/lm pairs has 
extended the targetable binding site size recognizable by the hairpin motif at high affinity 
(33,34). 
Figure 1.5. Space filling representation of the polyamide dimer ImHpPyPy-~-Dp bound in the minor 
groove of DNA. The figure was prepared using Insight II software and is deri~ed f~om a high-r~solut~on X-
ray co-crystal structure of a polyamide dimer bound to DNA, which was obtamed m collaboration With the 
Rees group at the California Institute of Technology. 
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Figure 1.6. Representative motifs for polyamide:DNA recognition. Red and blue circles represent 
imidazole and pyrrole residues, respectively. (3-Alanine and the y-tum are depicted as green diamonds and 
curved lines, respectively. The plus sign represents the dimethylaminopropylamide tail. 
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A variety of motifs for sequence specific recognition using the polyamide scaffold 
have been successfully developed for target sites from 5-16 bp (Figure 1.6) (29-31, 35-
41). For longer sequences, the introduction of a flexible p-alanine allows the polyamide 
that would otherwise be overwrought relative to the DNA helix to track the minor groove 
(29, 32, 34, 38, 42). Cooperative 2:1 dimer motifs are particularly attractive for future 
applications due to the low molecular weight of the monomer units (36). Binding of sites 
up to 16 bp, potentially sufficient for recognition of a unique sequence in the human 
genome, have been successfully targeted (37). Closing the ends of a hairpin polyamide 
with a second yaffords the cycle motif which can increase polyamide affinity (40, 41). 
The incorporation of a stereospecific a-amino group into the y turn also increases 
polyamide affinity and specificity, while allowing for functional moieties to be linked or 
the construction of a tandem motif by linking the C-terminus of another polyamide to this 





Figure 1.7. Inhibition of gene transcription by hairpin polyamides. A pair of hairpin polyarnides targeted to 
the DNA sequences adjacent to the binding sites for LEF-l and TBP inhibit assembly of the transcriptional 
machinery and transcription of the HIV -1 gene in human cell culture. 
Gene Regulation by Polyamides 
As an initial step toward asking whether cell-permeable small molecule 
transcription agonists might regulate gene expression in complex organism, regulation of 
transcription in specific genes by polyamides has been studied. The DNA-binding 
activity of the 5S RNA specific transcription factor TFIIIA was inhibited by an eight-ring 
hairpin polyamide that bound within the recognition site of the nine-zinc-finger protein in 
the minor groove. Transcription of 5S RNA genes by RNA polymerase III was 
suppressed in vitro and in cultured Xenopus kidney cells (5). Polyamides have also been 
shown to downregulate genes transcribed by RNA polymerase II. Two hairpin 
polyamides were targeted to DNA sequences adjacent to DNA sequences immediately 
adjacent to the binding site of transcription factors, Ets-1, LEF-1 and TBP in the HIV-1 
enhancer/promoter. These synthetic ligands inhibit DNA-binding of each transcription 
factor and HIV-1 transcription in cell-free assays. Treatment of isolated human peripheral 
blood lymphocytes with the two hairpin polyamides demonstrated inhibition of viral 
replication (33). In an effort to create an artificial activator, capable of upregulating gene 
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expression, a hairpin polyamide was tethered to a short peptide (20mer) activation 
domain (AH). The conjugate successfully upregulated transcription in a cell-free system 
(44). 
Scope of this Work 
This thesis describes work including development of new methodologies for 
synthesizing polyamides, application of new polyamide motifs toward protein inhibition 
and synthesis and evaluation of sequence specific alkylating agents. 
Chapters 2 and 3 describe two alternative synthesis routes to access polyamides 
that complement previously reported Boc solid phase synthesis methodology. In Chapter 
2 details a Fmoc solid phase synthesis method that is amenable to both manual and 
machine-assisted strategies. Purities and yields were equal or better to those reported with 
Boc-chemistry. Chapter 3 introduces access of polyamides with truncated tails by 
synthesis on Rink resin using Fmoc monomers or using Boc monomers on oxime resin. 
The new tails allow binding of all four base pairs at the tail position expanding the range 
of DNA sequences that can be targeted with high affinity by hairpin polyamides. 
Chapters 4 and 5 report the inhibition of protein:DNA complex formation by 
hairpin polyamides. Chapter 4 presents the inhibition of major groove-binding GCN4 by 
polyamides by targeting specific protein-DNA contacts along the phosphate backbone 
with positively charged alkylamino substituents off the pyrrole ring. Relocation of the 
positive charge from the ring to the tail resulted in a tenfold increase in binding affinity 
with uncompromised specificity. Chapter 5 demonstrates the inhibition of DNA-binding 
by NF-KB. Inhibition of the p50p65 NFkB heterodimer is successful only when a 
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polyamide is targeted to the 5' -000AC-3' subsite. A new polyamide motif is reported 
that binds a 3'-0000-5' site with subnanomolar affinity. 
Chapters 6 and 7 describe the creation of a new class of sequence specific 
alkylators by the combination of DNA binding polyamides with the classic, nonspecific 
alkylator, chlorambucil. Chapter 6 describes the synthesis of a polyamide-chlorambucil 
conjugate targeted to the HIV -1 promoter region. The yield and specificity of alkylation 
is determined by thermal cleavage assays on a 241 bp restriction fragment. Chapter 7 
describes pharmacological data of polyamide-chlorambucil conjugates. Alkylation of the 
HIV -1 promoter in genomic DNA in cells and compared to alkylation of naked genomic 
DNA. The varying toxicity of the compounds to various cell lines and effects of cell 
cycles is reported. 
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CHAPTER 2 
Fmoc Solid Phase Synthesis of Poly ami des Containing Pyrrole 
and Imidazole Amino Acids 
The text (~fthis chapter was taken in partfrom a publication co-authored with James M. 
Turner, Eldon E. Baird & Prof Peter B. Dervan. 
(N. R. Wurtz, 1. M. Turner, E. E. Baird & P. B. Dervan Org. Lett., 2001, 3, 1201-1203.) 
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Abstract 
Polyamides containing N-methylimidazole (Im) and N-methylpyrrole (Py) amino 
acids are synthetic ligands that have an affinity and specificity for DNA comparable to 
many naturally occurring DNA-binding proteins. A machine assisted Fmoc solid phase 
synthesis of polyamides has been optimized to afford high stepwise coupling yields 
(>99%). Two monomer building blocks, Fmoc-Py acid and Fmoc-Im acid, were prepared 
in multi gram scale. Cleavage by aminolysis followed by HPLC purification affords up to 
200 mg quantities of polyamide with purities and yields greater than or equal to those 
reported using Boc chemistry. Additionally, an improved synthesis of Boc-Im acid is 
reported. A broader set of reaction conditions will increase the number and complexity of 
minor groove binding polyamides that may be prepared, and help ensure compatibility 
with many commercially available peptide synthesizers. 
18 
Introduction 
Small molecules specifically targeted to any predetermined DNA sequence would 
be useful tools in molecular biology and potentially in human medicine. Polyamides 
containing N-methylpyrrole (Py), 3-hydroxylpyrrole (Hp) and N-methylimidazole (lm) 
are synthetic ligands that have an affinity and specificity for DNA comparable to 
naturally occurring DNA binding proteins. DNA recognition depends on side-by-side 
aromatic amino acid pairings oriented N ~e with respect to the 5' ~ 3' direction of the 
DNA helix in the minor groove. An antiparallel pairing of 1m opposite Py (ImJPy pair) 
recognizes a G-e base pair, while a Py/lm combination recognizes e-G. A Hp/Py pair 
prefers T-A over A-T. A Py/Py pair is degenerate and recognizes either an A-T or T-A 
base pair (1). 
The large repertoire of pyrrole-imidazole polyamides synthesized hallmarks the 
development of Boc-chemistry solid phase polyamide synthesis (2). However, to ensure 
compatibility with most commercially available peptide synthesizers, we set out to 
develop an alternative solid phase synthesis incorporating a different protecting group 
that would provide a route to polyamides with comparable purity and recovery to Boc 
chemistry. The synthetic schemes made available by this new chemistry could make 
available a greater variety of bifunctional polyamide conjugates and derivatives. As a 
minimum first step, we report here monomer synthesis and general protocols for 
machine-assisted Fmoc-chemistry solid phase synthesis of pyrrole-imidazole polyamides, 
ImPyPyPy-y-PyPyPyPy-~-Dp 1 and ImPyPyPy-y-ImPyPyPy-~-Dp 2 (Figure 2.1), which 
are identical or superior in recovery, purity, and coupling times to Boc-chemistry 
protocols. 
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Figure 2.1. ImPyPyPy-y-PyPyPyPy-~-Dp (top) and ImPyPyPy-y-PyPyPyPy-~-Dp (bottom) prepared by 
multistep solid phase synthesis. 
The synthesis of Fmoc-Py acid has previously been reported (3, 4). We report a 
convenient multi gram scalable synthesis of Fmoc-Py acid with a higher overall yield 
without the use of column chromatography, as well as the first reported synthesis of 
Fmoc-Im acid (Figure 2.2). 
Results and Discussion 
Pyrrole monomer precursors 3a and 4a were synthesized using literature protocols 
(2). Previously reported 2-(trichloroacetyl)-1-methylimidazole 3b was converted to tert-
butyl 1-methylimidazole-2-carboxylate 4b using modifications of previously published 
procedures (5). Compound 3b in acetic anhydride was cooled to 0 0 C followed by the 
addition of fuming nitric acid and sulfuric acid over 2 h. Crystallization provided 528 g 
of 4b in 56% yield. tert-Butyl esters Sa and Sb were synthesized from 4a and 4b with 
tert-butoxide in refluxing tert-butanol yielding Sa and Sb in 95% and 84% respectively. 
Reduction of Sa and Sb in DMF in the presence of 10% Pd/C under 500 psi of hydrogen 
proceeds to completion in three hours. After filtering the reaction mixture through a pad 
of Celite, Fmoc-CI and diisopropylethylamine were added to provide 6a and 6b in 66% 
and 35% yield, respectively. The tert-butyl esters were deprotected with TiCl.) in 
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dichloromethane at 0° C to prevent the decarboxylation, which was observed with 
standard trifluoroacetic acid deprotection. Precipitation with 1.0 M HCl afforded the final 
products 7a and 7b in 88% and 86% yield, respectively. The overall yield from 
commercially available starting materials for the Fmoc-Py acid and Fmoc-Im acid are 



















Figure 2.2. (i) 90% nitric acid, Ac20; (ii) NaOMe/MeOH; (iii) NaOt-Bult-BuOH, (iv) 500 psi of H 2, 10% 
Pd/C, DMF; (v) Fmoc-Cl, DlEA; (vi) TiCI4 , CH2CI2 . 
Additionally, the first two steps of the Fmoc-Im acid synthesis provide a safer, 
higher yielding route to the Boc-Im acid monomer. The original published synthesis of 
the Boc-Im acid required acylation of N-methyl imidazole with ethyl chloroformate, 
followed by a highly exothermic nitration at the 4- and 5- positions in sulfuric acid and 
fuming nitric acid. The isomers were separated by a difficult recrystallizaton to provide 
the desired ethyl 1-methyl-4- nitroimidazole-2-carboxylate 8. In the new synthetic route, 
nitration of trichloroketone 3b in acetic anhydride provides the desired isomer, 4-nitro-2-
(trichloroacetyl)-I-methyl-imidazole 4b, by milder nitration conditions. The product was 
esterified with sodium ethoxide in ethanol to yield ethyl l-methyl-4-nitroimidazole-2-
carboxylate 8 in 95% yield (Figure 2.3). This intermediate was converted in three steps 
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into the desired Boc-Im acid 9 using previously reported reactions (2) in an improved 
overall yield of 18%, compared to the 8% overall yield in the original synthesis. 
4b 








For Fmoc solid phase synthesis, the polyamide was attached to an insoluble 
matrix by a linkage, which is cleaved in a single step, introducing a positive charge into 
the polyamide. Fmoc-~-alanine-Wang resin is commercially available in appropriate 
substitution levels (0.86 mmol/g). Manual solid phase synthesis uses HBTU/DIEA 
activation protocols as previously reported (2). 
Fmoc-chemistry machine-assisted solid phase polyamide synthesis protocols were 
modified from the Boc-chemistry protocols reported for use on an ABI 430A peptide 
synthesizer. Coupling cycles for machine-assisted synthesis are rapid, 180 min per 
residue, and require no special precautions beyond those used for ordinary solid phase 
peptide synthesis. Machine-assisted solid phase synthesis of a pyrrole-imidazole 
polyamide consists of a DCM wash, an NMP wash, removal of the Fmoc group with 
piperidine/NMP, an NMP wash, a DCM wash, an NMP wash, addition of activated 
monomer, coupling for 180 minutes, capping with acetic anhydride, taking a resin sample 
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Figure 2.4. Solid phase synthetic scheme for polyamides 1 and 2 starting from commercially available Fmoc-~­
alanine-Wang resin. (i) 20% piperidine/NMP; (ii) Fmoc-Py acid, HBTU, DIEA; (iii) 20% piperidine/NMP; (iv) Fmoc-
Py acid, HBTU, DIEA; (v) 20% piperidine/NMP; (vi) Fmoc-Py acid, HBTU, DIEA; (vii) 20% piperidine/NMP; (viii) 
Fmoc-Py acid (for 1) or Fmoc-Im acid (for 2), HBTU, DIEA; (ix) 20% piperidine/NMP; (x) Fmoc-y-aminobutyric acid, 
HBTU, DIEA; (xi) 20% piperidine/NMP; (xii) Fmoc-Py acid, HBTU, DIEA; (xiii) 20% piperidine/NMP; (xiv) Fmoc-
Py acid, HBTU, DIEA; (xv) 20% piperidine/NMP; (xvi) Fmoc-Py acid, HBTU, DIEA; (xvii) 20% piperidine/NMP; 
(xviii) 1m-acid, HBTU, DIEA; (xix) N, N-dimethylaminopropylamine, 55 0 C. 
Because the aromatic amine of the pyrrole and imidazole do not react III the 
quantitative ninhydrin test, stepwise cleavage of a sample of resin and analysis by HPLC 
is used to indicate that high stepwise yields (>99%) are routinely achieved. We note that 
coupling of the imidazole amine with Fmoc-Py-OBt ester was not satisfactory. However, 
acylation with Boc-Py anhydride ester (synthesized in situ using DCC, DMAP in DCM) 
proceeds to completion within 3 h (2). 
ImPyPyPy-y-PyPyPyPy-~-Dp 1 and ImPyPyPy-y-ImPyPyPy-~-Dp 2 were 
prepared in 19 steps using the protocols described in the experimental section (Figure 
2.4). The yield of each individual coupling step was established as >99% by HPLC 
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analysis. The resin was cleaved in high yield (>90%) by aminolysis with (N,N,-
dimethylamino)propylamine. A single HPLC purification of the eight-ring polyamide 
was sufficient to obtain a recovery of 38% and 9% for 1 and 2, respectively, and a final 
purity for both compounds greater than 98% as determined by a combination of 
analytical HPLC, I H NMR, and mass spectroscopy. 
Figure 2.5. Synthesis of N-methyl pyrrole polyamides by reduction of aryl-nitro groups on solid phase by 
tin (II) chloride dihydrate. 
Since other synthetic routes may be useful for accessing highly functionalized 
polyamides, synthesis of polyamides by reduction of aryl nitro groups was investigated. 
Aryl nitro groups can be selectively reduced to amines on solid phase by tin (II) chloride 
dihydrate (6-9). This route is advantageous since 4-nitropyrrole carboxylates are 
accessible at high yields from hydrolysis of the ethyl esters and provide a highly stable 
amine synthon at the 4-position. In this case, the desired 4-nitropyrrole carboxylate was 
observed to be a side product of the synthesis of Sa and isolated by acidifying and 
extracting the aqueous washes. The monomer coupled readily to a deprotected pyrrole on 
resin with HBTU/HOBt (Figure 4.5). Reduction of the nitro group with l.5 M tin (II) 
chloride dihydrate in dimethylformamide/acetonitrile (7: 1) proceeded to completion in 
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five days at 37° C with little decomposition observed. Deprotection was achieved in 12 
hours at 60° C with 2.0 M tin (II) chloride with some decomposition observed. This route 
of synthesis was not pursued in greater detail since the reduction was slow when 
compared to Boc or Fmoc de protection and offers no advantages over either of these 
routes for current synthetic applications. 
Conclusion 
Pyrrole-imidazole polyamides are a promising class of compounds used to target 
predetermined DNA sequences. The synthetic schemes made available by Fmoc-
chemistry solid phase will allow a greater variety of bifunctional conjugates and 
derivatives to be synthesized. 
Experimental 
Materials. Fmoc-p-alanine-p-benzyloxybenzyl alcohol resin (Fmoc-p-Wang-
resin), 2-( IH-benzotriazol-l-yl)-l, 1 ,3,3-tetramethyluronium hexafluorophosphate 
(HBTU), and Boc-y-Aminobutyric Acid were purchased from Peptides International. 
N,N-Diisopropylethylamine (DIEA), piperidine, and N-methylpyrrolidone (NMP) were 
purchased from Applied Biosystems. Dichloromethane (DCM) and triethylamine (TEA) 
were reagent grade from EM, 9-Fluorenylmethyl chloroformate (Fmoc-Cl), thiophenol 
(PhSH), (dimethylamino)propylamine, trichloroacetylchloride, N-methylpyrrole, and N-
methylimidazole were from Aldrich, and trifluoroacetic acid (TFA) was from 
Halocarbon. All reagents were used without further purification. 
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IH NMR spectra were recorded on a General Electric-QE NMR spectrometer at 
300 MHz in DMSO-d6 , with chemical shifts reported in parts per million relative to 
residual solvent. UV spectra were measured in water on a Hewlett-Packard Model 
8452A diode array spectrophotometer. Matrix-assisted, laser desorptionlionization time 
of flight mass spectrometry (MALDI-TOF) electrospray mass spectrometry were 
performed at the Protein and Peptide Microanalytical Facility at the California Institute of 
Technology. HPLC analysis was performed on either a HP 1090M analytical HPLC or a 
Beckman Gold system using a RAINEN C 1g , Microsorb MV, 5~m, 300 x 4.6 mm 
reversed phase column in 0.1 % (wt/v) TFA with acetonitrile as eluent and a flow rate of 
1.0 mUmin, gradient elution 1.25% acetonitrile/min. Preparatory reversed phase HPLC 
was performed on a Beckman HPLC with a Waters DeltaPak 25 x 100 mm, 1 00 ~m C 18 
column equipped with a guard, 0.1 % (wt/v) TFA, 8.0 ml/min, 0.25% acetonitrile/min. 
18MW water was obtained from a Millipore MilliQ water purification system, and all 
buffers were 0.2 ~m filtered. 
Monomer Synthesis. 
tert-Butyl 4-Nitro-l-methylpyrrole-2-carboxylate (Sa). To a suspension of 4-nitro-2-
(trichloroacetyl)-l-methylpyrrole (4a) (50 g, 19.5 mmo!) in 500 ml of tert-butyl alcohol 
was added sodium tert-butoxide (25 g) over 1 hour. The suspension was refluxed under 
argon for 5 hours. The mixture was quenched with 500 ml of water and extracted with 
chloroform (3 X 500 mI). The chloroform was concentrated in vacuo to provide Sa (39.4 
g, 94.6% yield). TLC (3: 1 hexanes: ethyl acetate) R1 0.52 IH NMR (DMSO-d6 ) 8 8.18 (d, 
1 H, J = 2.4), 7.18 (d, 1 H, J = 2.4), 3.97 (s, 3 H), 1.47 (s, 9 H). FABMS mle 226.096 
(226.095 ca1cd for C IOH 1.jN 20.j). 
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tert-Buty I 4- [(9-Fluorenylrnethoxycarbonyl)arnino ]-1-rnethylpyrrole-2-
carboxylate (6a). To a solution of tert-Butyl 4-Nitro-l-methylpyrrole-2-carboxylate (Sa) 
(20.0 g, 88.4 mmol) in 100 ml of DMF was added 10% Pd/C (2 g) in 20 ml of DMF. The 
mixture was vigorously stirred for 2 h under 500 psi of hydrogen, filtered though Celite, 
and the Celite was washed with DMF (1 x 200 ml). The two filtrates were combined, 
Fmoc-CI (25.3 g, 92.8 mmol) and DIEA (35 ml, 200 mmol) were added and the solution 
was stirred for 10 h. Water (250 ml) was added, and the mixture extracted with ethyl 
ether (2 x 500 ml). The ether was dried (sodium sulfate) and concentrated in vacuo to 
-200 ml. Hexanes was added to preciptitate a brown solid which was washed with cold 
methanol/H20 to yield 6a as a white solid (24.3 g, 66% yield). TLC (3: 1 hexanes/ethyl 
acetate) RI 0.39 IH NMR (DMSO-d6 ) b 9.45 (s, 1 H), 7.92 (m, 2 H), 7.71 (m, 2 H), 7.44 
(m, 2 H), 7.36 (m, 2 H), 7.03 (d, 1 H, J = 2.4), 6.63 (d, 1 H, J = 2.4), 4.45 (d, 2 H, J = 
6.3),4.31 (t, 1 H, J = 6.3), 3.78 (s, 3 H), 1.50 (s, 9 H). FABMS rn/e 418.189 (418.189 
calcd for C2sH26N204). 
4-[ (9-Fluorenylrnethoxycarbonyl)arnino ]-1-rnethylpyrrole-2-carboxylic acid 
(7a). tert-Butyl 4-[(9-Fluorenylmethoxycarbonyl)amino]-I-methylpyrrole-2-carboxylate 
(6a) (5.0 g, 12.0 mmol) was dissolved in 100 ml of dichloromethane and cooled to 0° C. 
TiCl4 (25 ml, 1.0 M in dichloromethane) was added dropwise to the solution. The 
mixture was stirred for 30 min. 1 M HCI (250 ml) was cooled to 4 °C and added 
dropwise. The resulting white precipitate (7a) was collected by vacuum filtration and 
washed with a small amount of cold water and dried in vacuo (3.8 g, 88% yield). TLC 
0:1 hexanes/ethyl acetate) RI O.15 IH NMR (DMSO-d6 ) b 12.16 (bs, 1 H), 9.45 (s, 1 H), 
7.92 (m, 2 H), 7.74 (m, 2 H), 7.44 (m, 2 H), 7.36 (m, 2 H), 7.07 (d, 1 H, J = 2.4),6.64 (d, 
1 H, J = 2.4), 4.46 (d, 2 H, J = 6.3), 4.30 (t, 1 H, J = 6.3), 3.80 (s, 3 H). FABMS rn/e 
362.127 (362.126 calcd for C2IHISN204). 
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4-Nitro-2-(trichloroacetyl)-1-methylimidazole (4b). A solution of 2-
(tricholoroacteyl)-I-methylimidazole (700 g, 3.1 mol) in 4 L of acetic anhydride was 
cooled to -400 C. Fuming nitric acid (500 ml), followed by conc. sulfuric acid (25 ml) 
was added over 2 h, and the reaction mixture was stirred for 12 h. The mixture was 
poured into a tray and allowed to crystallize over two days. The product was collected by 
vacuum filtration, washed (cold water, 1 x 100 ml), and dried in vacuo to yield 4b as a 
white crystalline solid (472 g, 56% yield). TLC (1:1 hexanes/ethyl acetate) R f 0.57 'H 
NMR (DMSO-d6 ) 8 8.84 (s, 1 H), 4.04 (s, 3 H). FABMS mJe 270.932 (270.932 calcd 
for C6H .. N,OJ. 
tert-Butyl 4-Nitro-l-methylimidazole-2-carboxylate (5b). To a mixture of 4-
nitro-2-(trichloroacetyl)-1-methylimidazole (3b) (50 g, 0.18 mol) in 500 ml of tert-butyl 
alcohol was added sodium tert-butoxide (20 g) over 1 h. The reaction was refluxed under 
argon for 5 h, then quenched with 500 ml of water and extracted with chloroform (3 x 
500 ml). The chloroform was removed in vacuo to provide 5b (36.4 g, 84% yield). TLC 
0:1 hexanes/ethyl acetate) Rf O.59 'H NMR (DMSO-do) 8 8.62 (s, 1 H), 3.98 (s, 3 H), 
1.58 (s, 9 H). FABMS mJe 227.091 (227.091 calcd for C')HI3N,O .. ). 
tert-Butyl 4-[ (9-Fluorenylmethoxycarbonyl)amino] -1-methylimidazole-2-
carboxylate (6b). tert-ButyI4-Nitro-l-methylimidazole-2-carboxylate (5b) (9.2 g, 40 
mmol) was dissolved in 100 ml of DMF. 10% Pd/C (1 g) in 20 ml of DMF was added. 
The mixture was vigorously stirred for 2 h under 500 psi of Hydrogen and then filtered 
though Celite. The Celite was rinsed with DMF (200 mI). Fmoc-Cl (10.7 g, 41 mmol) 
was added and the solution was stirred for 3 h. Water was added to the DMF and the 
mixture was extracted with diethyl ether. The ether was extracted 2 x water and 1 x 
brine, dried over sodium sulfate and concentrated by rotoevaporation to yield a crude 
yellow solid which was dissolved in a minimum amount of diethyl ether. Purified by 
column chromatography (3: 1 hexanes/ethyl acetate, 5.9 g, 34.4% yield). TLC (1: 1 
hexanes/ethyl acetate) R, 0.64 'H NMR (DMSO-dlj) 8 10.4 (s, 1 H), 7.9 (d, 2 H), 7.7 (d, 2 
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H), 7.4 (m, 2 H), 7.3 (m, 2 H), 7.2 (s, IH), ),4.4 (d, 2 H, J = 6), 4.3 (t, 1 H, J = 6),3.9 (s, 
3 H), l.6 (s, 9 H). FABMS mJe 419.185 (419.184 calcd for C24H2SN304). 
4-[ (9-Fluorenylmethoxycarbonyl)amino] -1-methylimidazole-2-carboxylic 
Acid (7b). tert-Butyl 4-[(9-Fluorenylmethoxycarbonyl)amino]-I-methylimidazole-2-
carboxylate (6b) (5.0 g, 1l.9 mmol) was dissolved in 100 ml of dichloromethane and 
cooled to 0° C. TiCl4 (25 ml, l.0 M in dichloromethane) was added dropwise to the 
solution. The mixture was stirred for 1 h. Cold HCl (1 M, 500 ml) was added. The 
white precipitate was collected by vacuum filtration (3.7 g, 86% yield). 'H NMR 
(DMSO-d6 ) 8 12.4 (bs, 1 H), 10.4 (s, 1 H), 7.9 (d, 2 H), 7.7 (d, 2 H), 7.4 (m, 2 H), 7.3 
(m, 2 H), 7.2 (s, IH), ),4.4 (d, 2 H, J = 6), 4.3 (t, 1 H, J = 6), 3.9 (s, 3 H). FABMS mJe 
364.131 (M+H) (364.122 calcd for C2oH17N304). 
Solid Phase Synthesis. Activation of Fmoc-Imidazole Acid. Activation of 
Imidazole-2-carboxylic acid, Fmoc-Pyrrole acid, Fmoc-Imidazole acid and 'Y-
aminobutyric acid. The appropriate amino acid or acid (2 mmol) was dissolved in 2 mL 
of DMF. HBTU (720 mg, l.9 mmol) was added followed by DIEA (l mL) and the 
solution was lightly shaken for at least 5 min. 
Machine-Assisted Protocols. Machine-assisted synthesis was performed on an 
ABI 430A synthesizer on a 0.69 mmol scale (800 mg resin; 0.86 mmol/g). Each cycle of 
amino acid addition involved deprotection with approximately 80% PiperidineINMP for 
3 min, draining the reaction vessel, and then deprotection for 17 min; two NMP washes; a 
DCM wash; an NMP wash; draining the reaction vessel; coupling for 1 h (8 h when 
coupling to imidazole), addition of dimethyl sulfoxide (DMSO)/NMP, coupling for 30 
min; draining the reaction vessel; washing with DCM, taking a resin sample for 
evaluation of the progress of the synthesis for HPLC analysis; capping with acetic 
anhydride/DIEA in DCM for 6 min; and washing with DCM. 
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The ABI 430A synthesizer was left in the standard hardware configuration for 
NMP-HOBt protocols. Reagent position 1 was piperidine, reagent position 2 was not 
used, reagent position 3 was 70% ethanolamine/methanol, reagent position 4 was acetic 
anhydride, reagent position 5 was DMSOINMP, reagent position 6 was methanol, reagent 
position 7 was DIEA, and reagent position 8 was NMP. 
Fmoc-Im acid was added manually. Fmoc-imidazole acid (363 mg, 1 mmol) and 
HBTU (378 mg, I mmol) were combined in 2 mL of NMP. DIEA (1 ml) was then 
added, and the reaction mixture was allowed to stand for 5 min. At the initiation of the 
coupling cycle the synthesis was interrupted, the reaction vessel vented, and the activated 
monomer added directly to the reaction vessel. When manual addition was necessary, an 
empty synthesis cartridge was used. 
Fmoc-Py acid (362 mg, 1 mmol) and aliphatic amino acids (2 mmol) were placed 
in a synthesis cartridge with 0.9 equiv. HBTU. NMP (3 ml) was added using a calibrated 
delivery loop from reagent bottle 8, followed by a calibrated delivery of 1 mL of DIEA 
from reagent bottle 7, and a 3 min mixing of the cartridge. 
The activator cycle was written to transfer activated monomer directly from the 
cartridge to the concentrator vessel, bypassing the activator vessel. After transfer, 1 mL 
of DIEA was measured into the cartridge using a calibrated delivery loop, and the DIEA 
solution was combined with the activated monomer solution in the concentrator vessel. 
The activated ester in 2: 1 DMF/DIEA was then transferred to the reaction vessel. All 
lines were emptied with argon before and after solution transfers. 
ImPYPYPY-'Y-PyPyPyPy-~-Dp (1). ImPyPyPy-y-PyPyPyPy-~-Wang reSlll was 
prepared by machine-assisted synthesis protocols. A sample of resin (l g, 0.47 mmol/g) 
was placed in a 20 mL glass scintillation vial. 4 mL of N,N-(dimethylamino) propyl amine 
added, and the solution heated at 55° C for 18 h. Resin was removed by filtration through 
a disposable propylene filter, and 16 mL of water was added. The polyamide/amine 
mixture was purified directly by preparatory HPLC, and the appropriate fractions were 
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lyophilized to provide the trifluoroacetate salt of ImPyPyPy-y-PyPyPyPy-f3-Dp (240 mg, 
38% recovery) as a white powder. MALDI-TOF-MS (monoisotopic), 1221.5 (1221.6 
calc. for M+H). 
ImPyPyPy-y-ImPyPyPy-f3-Dp (2). ImPyPyPy-y-PyPyPyPy-f3-Wang resin was 
prepared by machine-assisted synthesis protocols. A sample of resin (1 g, 0.47 mmol/g) 
was placed in a 20 mL glass scintillation vial. 4 mL of (dimethylamino)propylamine 
added, and the solution heated at 55 DC for 18 h. Resin was removed by filtration through 
a disposable propylene filter, and 16 mL of water was added. The polyamide/amine 
mixture was purified directly by preparatory HPLC, and the appropriate fractions were 
lyophilized to provide the trifluoroacetate salt of ImPyPyPy-y-ImPyPyPy-f3-Dp (57 mg, 
9% recovery) as a white powder. MALDI-TOF-MS (monoisotopic), 1222.5 (1222.6 calc. 
for M+H). 
Stepwise HPLC Analysis. A resin sample (ca. 4 mg) was placed in a 4 mL glass 
test tube. 200 mL of (N,N-dimethylamino)propylamine was added, and the mixture was 
heated at 100 0 C for 5 min. The cleavage mixture was filtered and a 25 mL sample 
analyzed by analytical HPLC at 254 nm. 
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CHAPTER 3 
Solid Phase Synthesis of Six-ring Polyamides with Truncated 
C-Terminal Tails 
The text of this chapter was taken in part from a publication co-authored with Jason 
Belitsky, Doan H. Nguyen & Prof Peter B. Dervan. 
o. M. Belitsky, D. H. Nguyen, N. R. Wurtz & P. B. Dervan Bioorganic & Medicinal 
Chemistry submitted 2001) 
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Abstract 
Pyrrole-imidazole polyamides are synthetic ligands that bind to predetermined sequences 
of DNA in the minor groove. Typically, solid phase methods using Boc monomers for 
synthesis have depended on Boc-~-Ala-PAM resin, which affords a ~-alanine-Dp tail at 
the C-terminus, after cleavage with N, N-dimethylaminopropylamine (Dp). New solid 
phase strategies, including Boc chemistry on Kaiser oxime resin, have permitted the 
synthesis of polyamides with truncated C-terminal tails in high yield. Polyamides having 
carboxylic acid, ethyl, methyl, and primary amide tails show increased generality in the 
tail region relative to the standard ~-Dp tail obtained from Boc-~-Ala-PAM resin 
synthesis. Polyamides with methyl amide tails rather than ~-alanine show similar affinity 
relative to the standard ~-Dp tail. The diminished preference for the A,T base pairs of 
truncated tails energetic will allow targeting of a greater number of DNA sequences by 
hairpin polyamides with high affinity. 
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Introduction 
Hairpin polyamides containing N-methylpyrrole (Py), N-methylimidazole (lm), 
and N-methyl-3-hydroxypyrrole (Hp) residues bind specific predetermined sequences in 
the minor groove of DNA with affinities and specificities comparable to naturally 
occurring DNA-binding proteins (1). DNA recognition depends on the side-by-side 
amino acid pairings in the minor groove that stack the aromatic rings against each other 
and the walls of the groove allowing backbone amide hydrogens and the substituents at 
the 3-position of the Py, 1m, and Hp residues to make specific contacts with the edges of 
the DNA base pairs. An ImlPy and Py/lm specifies for G-C and C-G, respectively. A 
Py/Py pair binds A-T and T-A and an Hp/Py pair discriminates T-A over A-T base 
paIrs. These modular ring pairs may be considered the "core" of the polyamide 
recognition motif. For hairpins an alkyl amino acid, either y-aminohutyric acid (GAB A, 
y), or the chiral, amine-functionalized derivative (R)-2,4-diaminobutyric acid (DABA, 
(R)H2Ny), serves as the covalent linker region (referred to as the "turn") between the N-
terminal and C-terminal strands and is specific for A-T and T-A base pairs. The "tail" or 
C-terminal portion of a typical hairpin polyamide is related to the method of synthesis 
and comprises ~-alanine (~) and N,N-dimethylaminopropylamine (Dp), which specify for 
A,T base pairs at the N-I and N-2 positions (Figure 3.1) (1). 
The ~-Dp tail originated with the C~N synthesis of polyamides by solid phase 
methods using Boc monomers on Boc-~-alanine-PAM-resin (2, 3). An alkyl primary 
amine such as Dp affords efficient cleavage from the solid support by aminolysis of the 
~-alanine ester linkage to the resin. The sequence requirements of the ~-Dp tail for A,T 
versus G,C at the N-I and N-2 positions (4) presumably results from a steric clash with 
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the exocyclic NH2 of a G,C base pair on the floor of the minor groove of DNA (Figure 1). 
Replacement of the ~-Dp tail with a shorter propanol amide, generated by the reductive 
cleavage of the ~-alanine-P AM ester from the solid support (5), removes the preference 
for an A,T base pair at the N-2 position while maintaining the binding affinity for these 
sites, despite the loss of a positive change (4). This suggests that the Dp tail interaction 
with the minor groove may be sterically unfavorable. A deeper understanding of the 
effect of incremental changes to the tail on the energetics of DNA binding would provide 
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Figure 3.1. Binding model for polyamide 1 with DNA. (left) Circles with dots represent lone pairs of N3 
of purines and 02 of pyrimidines. Circles containing an H represent the N2 hydrogens of guanine. 
Putative hydrogen bonds are illustrated by dotted lines. The series of truncated tails to be examined are 
denoted. (right) A ball and stick representation of polyamide 1 with DNA. Filled circles denote imidazole 
while open circles represent pyrrole. The diamond represents ~-alanine. (R)-diaminobutyric acid «R)H21' 1J 
and dimethylaminopropylamine (Dp) are depicted as a curved line and a plus sign, respectively. W 
signifies A or T, N represents any nucleotide. 
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In order to incrementally truncate the polyamide C-terminus, new solid phase 
methodology would be required since the propanol amide tail is the shortest C-terminus 
that can be generated from cleavage of Boc-p-Ala-PAM resin. Since the reductive 
cleavage to generate the propanol amide tail does not proceed reliably and results in poor 
overall recovery, it is generally not used. Therefore, for high affinity recognition hairpin 
polyamides are synthesized with P-Dp tails which require DNA binding sites to be 
composed of the sequence 5'-WW(N)xW-3' (W = A,T; N = A,T,G,C; and x = the number 
of ring pairs in the core of the polyamide). While a large number of biologically relevant 
sequences have been targeted by the current generation of hairpin polyamides (6). the 
necessity for A,T base pairs flanking the polyamide core is a limitation. Promoters are 
known to have high G,C content associated with CpG islands (7). and many transcription 
factors bind G,C rich sequences (8). In order to effectively inhibit these transcription 
factors, polyamides that can readily target all base pairs at the tail positions with high 
affinity are desirable. 
We describe here a new solid phase synthesis with a pyrrole unit directly linked to 
the Kaiser oxime resin as well as an adaptation of Fmoc solid phase synthesis to Rink 
resin. Six-ring polyamide hairpins with the common core sequence ImImPy-(R)H2Ny_ 
ImPyPy-X (3-6) were synthesized where X represents four different C-terminal tails, 
ethyl amide, methyl amide, primary amide, and carboxylic acid. The DNA-binding 
affinity and specificity at the N -1 position was compared to the parent polyamides having 




I 0 ~;r 'N ) N, Jl)'.-N H 
~ 1/ 'N ~ ~N H N" NH+ 
~ . ..J!.)i 0 3 
~yQ 1r '~ 
HO~~~ 0 ~ 
o I 
H N r:l. 1 ImlmPy-(R) 2 y-ImPyPy-p-Dp 2 ImImPy-(R)H2Ny-ImPyPy-PrOH 
I 0 
~,1 ~NH 
I 0 ~;r 'N ) N, Jl)'.-N H 
~ 1/ 'N ~ ~N H H N" NHi 
N. Y.)i 0 
H f!( If 'N 
N
rN
./ 0 I 
R~ 0 ~ 
o I 
3 ImlmPy-(R)H2Ny-ImPyPy-CO- R=NHEt 
4 ImlmPy-(R)H2Ny-ImPyPy-CO- R=NHMe 
5 ImlmPy-(R)H2Ny-ImPyPy-CO- R=NH2 
6 ImImPy-(R)H2 Ny-ImPypy-CO- R=OH 
Figure 3.2. Structures of polyamides ImlmPy_(R)H2:-i ylmPyPy-[3-Dp (1), ImlmPy-(Rt2Ny-ImPyPy-PrOH 
(2), ImlmPy-(R)H2:-iy-ImPyPy-CONHEt (3), ImlmPy-(R)H2Ny-ImPypy-CONHMe (4), ImlmPy-
(R)1I2NlmPyPy-CONH2 (5) and ImlmPy-(R)H2Ny-ImPyPy-C02H (6). 
Results 
Polyamide Synthesis. Polyamides ImlmPy-(R)H2Ny-ImPyPy-~-Dp (1) and 
ImlmPy-(Rt2Ny-ImPyPy-PrOH (2) were synthesized by solid phase methods on Boc-~-
alanine-PAM-resin (2, 3). The synthesis of Fmoc-protected Py (7) and 1m (8) monomers 
and the production of ~-Dp tail poly ami des from Fmoc-~-alanine-Wang resin has 
recently been described (9). The Fmoc-protected monomers can also be used for the 
straightforward synthesis of polyamides with C-terminal primary amides. Commercially 
available Fmoc-Rink resin was deprotected with piperidine, and reacted with Fmoc-Py 
activated with HBTU and DIEA (12). Six standard cycles of deprotection and coupling 
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(9) yielded ImlmPy-(R)BOCHNy-ImPyPyCONH-Rink resin which was cleaved with TFA to 
yield 5 (Figure 3.3). Similar cleavage yields and purities were obtained compared to 
synthesis of the analogous polyamide with standard Boc protocols on Boc-p-Ala-PAM 
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Figure 3.3. Synthesis of polyamide 3 from Rink resin using Fmoc-protected monomers: (i) 20% 
piperidine/DMF; (ii) 7, HBTU, DIEA, NMP; (iii) 20% piperidine/DMF; (iv) 7 , HBTU, DIEA, NMP; (v) 
20% piperidinelDMF; (vi) 8, HBTU, DIEA, NMP; (vii) piperidine/DMF; (viii) 10, HBTU, DIEA, NMP, 
37 °C; (ix) piperidine/DMF; (x) 7, HBTU, DIEA, NMP; (xi) piperidine/DMF; (xi) 8, HBTU, DIEA, NMP; 
(xii) piperidine/DMF; (xiii) 9, HBTU, DIEA, NMP; (xiv) TFA. 
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Four new polyamides 3-6 were synthesized by solid phase methods on the Kaiser 
oxime resin with Boc-pyrrole and Boc-imidazole monomers (Figure 3.4). Developed by 
Kaiser and DeGrado (10, 11), the oxime resin is a versatile polystyrene solid support that 
is amenable to Boc chemistry and allows for the synthesis of a variety of carboxylic acid 
derivatives by nucleophilic cleavage from the resin. Peptides can be cleaved from oxime 
resin to yield primary amide (11), alkyl amide (12), and carboxylic acid (13, 14) C-
termini. The oxime linker is reported to be somewhat acid labile, and solutions of less 
than 25% TFA are recommended for the deprotection of Boc groups. Consequently, a 
20% TFA/CH2Cl 2 solution was used for 30 minutes to remove the Boc groups from 
pyrrole and aliphatic amines. However, it was found that Boc-imidazole residues could 
not be fully deprotected under these conditions. Longer deprotection times resulted in 
increasing degradation of the resin bound polyamide. Boc groups could be efficiently 
removed from imidazoles in 30 minutes with a 50% TFA/CH2Cl2 solution. Remarkably, 
no premature cleavage of the oxime linker was observed at this higher concentration of 
acid. Attachment of the first pyrrole unit results in a bulky aromatic oxime ester that 
apparently stabilizes the linker relative to the aliphatic oxime ester present when 
conventional amino acids are used. 
Polyamides 3-6 were generated from the common intermediate, ImlmPy-
(R)llllllCHNy_ImPyPy_Oxime resin 15 (Figure 3.4). Commercially available oxime resin 
was allowed to react directly with Boc-Py-OBt (11) in N-methylpyrrolidone (NMP) and 
diisopropylethylamine (OlEA) overnight at room temperature. The subsequent 
deprotections and couplings were carried out in a stepwise manner using the previously 





















Figure 3.4. Synthesis of polyamide 3-6 from oxime resin using Boc-protected monomers: (i) 11, DIEA, 
NMP; (ii) 20% TFAIDCM; (iii) 11, DIEA, NMP; (v) 20% TFA/DCM; (v) 12, HBTU, DIEA, NMP; (vi) 
50% TFAIDCM; (vii) 13, HBTU, DIEA, NMP, 37 DC; (viii) 20% TFAIDCM; (ix) 11, DIEA, NMP; (x) 
20% TFA/DCM; (xi) 14, HBTU, DIEA, NMP; (xii) a) R = NHEt, 2.0 M CH3CH2NH/THF, DCM, 37DC; 
b) R = NHMe, 2.0 M CH3NH/THF, DCM, 37 DC; c) R = NH2 , NH3/THF, DCM, DBU, 37DC; or d) R = 
OH, H20, DMF, DBU, 37 o0e. 
coupled in NMP/DIEA for 1.5-8 hrs at either room temperature or 37°C. All cleavages 
of resin 15 required a co-solvent (CH2Cl2 or DMF) to swell the resin and/or solubilize the 
polyamide. Based on literature methods (11), cleavage of resin 15 with a saturated 
solution of ammonia in THF/CH2Cl2 yielded polyamide 5. However, even after more 
than 60 hrs at 37°C only 60% cleavage was observed. Addition of a large excess of 
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DBU, which had been used as a trans acylation catalyst to generate peptide acids and 
esters from oxime resin previously (13), resulted in quantitative cleavage of the resin to 
generate polyamide 5. The C-terminal carboxylic acid polyamide 6 was generated in a 
similar manner with 1: 1 H20:DMF, 30 eq. DBU for 60 hrs at 37°C. This method was 
superior to acidic, basic, or reductive cleavage conditions. It is interesting to note that the 
standard transacylation catalyst, DMAP, was ineffective as a replacement for DBU in 
these cleavage reactions. Both polyamides 3 and 4 were generated in high yield from 
resin 15 with a l.0 M solution in THF/CH 2C 12 of ethyl amine or methylamine, 
respectively, overnight at 37°C. The oxime resin is a versatile way to generate modified 
polyamides under mild conditions in good yield while remaining amenable to Boc 
chemistry. 
Quantitative DNase I Footprinting. It has been shown previously that 
elimination of Dp in the ~-Dp tail in polyamide 1 diminishes the requirement for A,T 
preference at the N-2 position (4). While empirical observations (15) have suggested that 
the propanol amide tail, like the ~-Dp tail (2) is A,T specific at the N-l position, this had 
not been investigated in detail. Quantitative DNase I footprinting titrations (16) were 
used to determine the equilibrium association constants (Ka) of polyamides 2-6 for four 
sites on a restriction fragment corresponding to the sequences 5'-AXGGCTA-3'(where X 
= A,T,G,C) at the N-l position (Figure 4A-D, Table 1). Conversion from ~-Dp (1) to 
propanol amide (2) results in similar affinity and specificity. This retention of affinity 
upon removal of the positively charged Dp moiety has previously been observed (17, 18). 
Presumably, the steric clash of propanol amide versus ~-Dp with the exocyclic NH2 of G 
at N -1 is similar. 
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Figure 4 A&B. Quantitative DNase I footprint titration experiment with ImlmPY-(R)1I2Ny-ImPyPyPrOH (2) 
and ImlmPy-(R)H2Ny-ImPyPyCONHCH3 (4) on the 3,-
32P-labeled 286-bp restriction fragment pSES-
TLI(4): lane I & 23, intact DNA; lane 2 & 22, A reaction; lane 3 & 21, G reaction; lane 4 & 20 DNase I 
standard; lanes 5-19 DNase I digestion products in the presence of I J.lM, 500 nM, 200 nM, 100 nM, 20 
nM, 10 nM, 5 nM, 2 nM, I nM, 500 pM, 200 pM, 100 pM, 50 pM, 20 pM, 10 pM polyamide respectively. 
All reactions contain 15 kcpm restriction fragment, 10 mM TriseHCI (pH 7.0), 10 mM KCI, 10 mM MgCI2 , 
and 5 mM CaCI2• Data was obtained for the four binding sites indicated at the left of the gel, 5'-GGGCT-3', 
5'-AGGCT-3', 5'-CGGCT-3', and 5'-TGGCT-3', and is shown in the isotherm plot below. 8norm points were 
obtained using storage phosphor autoradiography and processed by standard methods. Each data point 
shows the average value obtained from three footprinting experiments. The solid curves arc best-fit 
Langmuir binding titration isotherms obtained from nonlinear least squares algorithm where n = I as 
previously described. (2) 
Polyamides 3-5 afford similar DNA binding affinity versus the parent ~-Dp while 
diminishing the sequence preference for A,T versus G,C at N-l. Polyamide 3 (ethyl 
amide) maintains a strong preference for A,T versus G,C, while polyamide 4 (methyl 
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Figure 4 C&D. Quantitative DNase I footprint titration experiment with ImlmPy-(R)H2'"'y-ImPyPyCONH2 
(5) and ImlmPy-(R)H2Ny-ImPyPyC02H (6) on the 3'-
32P-Iabeled 286-bp restriction fragment pSES-TLI (4): 
lane I & 24, intact DNA; lane 2 & 23, A reaction; lane 3 & 22, G reaction; lane 4 & 21 DNase I standard; 
lanes 5-20 DNase I digestion products in the presence of 111M, 500 nM, 200 nM, 100 nM, 50 nM, 20 nM, 
10 nM, 5 nM, 2 nM, I nM, 500 pM, 200 pM, 100 pM, 50 pM, 20 pM, 10 pM polyamide respectively. 
Conditions and data analysis as outlined in Figure 4 A&B. 
amide) less so. Polyamide 5 (primary amide) shows a loss in affinity relative to 1-4, and 
little sequence discrimination between the four Watson-Crick base pairs. Polyamide 6 
(carboxylic acid) reveals poor affinity and little sequence discrimination at the N-l 
position (Table I). The decreased affinity of polyamides 5 and 6 suggests that the 
increased Van der Waal contacts with the walls of the minor groove, made by polyamides 
1-4, may be important. 
R= -~-Dp (1) 
x·y 
A·T 1.7 X 109(±05) 5.9 X 108(±04) 
T'A 1.6 X 109(±02) 4.7 X 108(~04) 
G·e 58 X 107(-'014) 2.1 X 107(±03) 
e·G 32 X 107(±03) 6.2 X 106(107) 
5'-t A ~+ t a-3' 
3'-aTYCCGATa t-~' 
-NHCH3 (4) 
1.1 X 109(±01) 1.1 X 109( j 0 1 ) 
9.2 X 108( ,03) 14 X 109(,-03) 
8.2 X 107(±13) 2.4 X 108(101) 
3.0X 107(105) 1 1 X 108(102) 
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-NH2 (5) -OH (6) 
1.9 X 108("02) 2.1 X 107(±01) 
2 1 X 108(±02) 1.2 X 107(±02) 
6.8 X 107(&5) 1.1 X 107(.i02) 
3.5 X 10 7(±02) 4.9 X 106(±02) 
Table 3.1. Equilibrium association constants (MI) for poly ami des 1-6 with restriction fragment pSES-TL I. 
(4) Values reported are the mean values from at least three DNase I footprinting titration experiments with 
the standard deviation for each data set in parentheses. Equilibrium association constants for polyamide 1 
at the N-I position were obtained from Swalley et al. (4). 
Discussion 
In sequences with an A-T or T-A at the N-l position, structural evidence (19-24) 
suggests that the C-terminal pyrrole secondary amide makes a hydrogen bond with the 
N3 of adenine and/or the 02 of thymine (Figure 1). However, hydrogen bonds could also 
be made to the N3 of guanine and/or the 02 of cytosine. Assuming these hydrogen 
bonds are similar energetically, the discrimination of A,T versus G,C is likely due to 
steric reasons. Thus, the methylene groups of the propanol amide and ~-Dp tails clash 
with the exocyclic amine of guanine and by default incur a lower energetic penalty at 
A,T. The int1uence of the exocyclic amine of guanine on specificity can be inferred from 
the observation that the sequence XY = C-G was the lowest affinity site for all of the 
polyamides examined in this study. At this site the guanine base is on the bottom strand 
of the DNA proximal to the C-terminus of the hairpin where the steric clash between the 
tail and the exocyclic NH2 of guanine should be most severe. 
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Polyamides 3 and 4 with the ethyl and methyl amide tails provide a way to 
investigate whether specificity could be assigned to a particular methylene group of the 
propanol amide tail. The specific hydrogen bond made by the amide of the C-terminal 
pyrrole would point the first methylene group away from the floor of the minor groove, 
such that the energetic penalty and hence specificity might be attributable to the second 
methylene group. However, the methyl amide did exhibit about 8-fold preference for 
binding A,T or G,c. The ethyl amide tail disfavors both G-C and C-G sites by about 3-
fold more than the methyl amide tail. Clearly, both alkyl groups contribute to A,T 
specificity, and even greater steric bulk beyond the second carbon is likely necessary to 
account for the greater than 50-fold specificity of the ~-Dp and propanol amide tails. The 
high affinity of polyamides 3 and 4 suggest an energetic balance between increased Van 
der Waals contacts with the walls of the minor groove relative to the primary amide tail 
(5) and decreased steric clashing relative to the ~-Dp tail (1). 
Polyamides with C-terminal carboxylic acid tails have been synthesized as 
intermediates to cyclic polyamides but their DNA binding properties have not been 
investigated (25, 26). The carboxylic acid tail polyamide (6) binds all four sites with low 
affinity and poor sequence discrimination. To act as a hydrogen bond donor in analogy 
to the amides, the carboxylic acid would have to be protonated in the minor groove. The 
acid is likely deprotonated in the minor groove and the IO-fold lower affinity compared 
to the primary amide tail may be due to loss of this hydrogen bond. Additionally, in 
water polyamide 6 is expected to be a zwitterion with a net charge of zero, which one 
would expect to have a lower affinity for DNA than the positively charged polyamides 1-
5. 
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Figure 3.5. Summary of end effects by truncated polyamides. For the same DNA sequence a 20-fold 
increase is ohserved moving from ~-Dp polyamide 1 to propanol amide tail polyamide 2. A further 3-fold 
increase is ohserved in truncation of the propanol amide to the methyl amide tail polyamide 4. 
Conclusion 
In summary, hairpin polyamides with incrementally truncated C-terminal tails can 
be synthesized using Boc chemistry, in high yield, on oxime resin by solid phase methods 
(Figure 3.5). The polyamides are lower molecular weight than the corresponding ~-Dp 
polyamide and bind all four base pairs at the N-l position with high affinity, which will 
enable targeting of new biologically relevant sequences by hairpin polyamides. If, at the 
N-l position, one desires specificity for A,T > G,C while maintaining high affinity, then 
the propanol amide or the ethyl amide is the end group of choice. If at the N-l position, 
one prefers less sequence preference with high affinity, then the methyl amide is the best 
choice. It will be interesting to study the influence of truncated tails on cellular uptake 
and nuclear localization of hairpin polyamides. 
Experimental 
Materials. Polyamides 1 and 2, and the restriction fragment pSES-TLl have 
been previously described (4). DNase I footprinting titrations on the 12P-Iabeled 
restriction fragment pSES-TLl were performed as previously described (4). 2.0 M 
methylamine in THF, 2.0 Methylamine in THF, DBU and anhydrous ammonia gas were 
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purchased from Aldrich. Oxime resin was purchased from Nova Biochem. All other 
synthetic and footprinting reagents were as previously described (3, 16, 18). I H NMR 
were recorded on a Varian Mercury 300 instrument. UV spectra were measured on a 
Beckman Coulter DU 7400 diode array spectrophotometer. Autoradiography was 
performed with a Molecular Dynamics Tyhoon Phosphorimager. Matrix-assisted, laser 
desorption/ionization time of flight (MALDI-TOF) mass spectrometry was carried out at 
the Peptide and Protein Microanalytical Facility at the California Institute of Technology. 
HPLC analysis was performed on a Beckman Gold system using a RAINEN C 18 , 
Microsorb MV, 5 !-lm, 300 x 4.6 mm reversed-phase column in 0.1 % (w/v) TFA with 
CH,CN as eluent and a flow rate of 1.0 mUmin, gradient elution 1.25% CH3CN/min. 
Preparatory HPLC was carried out on a Beckman HPLC using a Waters DeltaPak 25 x 
100 mm, 100 !-lm CIS column, 0.1 % (w/v) TFA, 0.56% CH3CN/min. 18MQ water was 
obtained from a Millipore MilliQ water purification system, and all buffers were 0.2 !-lm 
filtered. Reagent-grade chemicals were used unless otherwise stated. 
ImlmPy_(R)H2Ny_ ImPy PyCONHEt (3). ImImPy _(R)BOCHNy_ ImPyPyCO-Oxime 
resin (15) was generated by manual solid phase synthesis from oxime resin (l g, 0.48 
mmol/g) using previously described Boc-protected monomers (3). Boc-Py-OBt (11) (358 
mg, 1 mmol) was dissolved in 2 ml of NMP and added to 1 g of oxime resin followed by 
1 ml of DIEA. The coupling was allowed to proceed overnight at room temperature. The 
resin was then acetylated with 3 ml of acetic anhydride (Ac20), 4 ml of NMP and 1 ml of 
DIEA for 30 minutes at room temperature. The Boc group was removed upon treatment 
with 20% TFA/DCM for 30 minutes. The second pyrrole residue was coupled in the 
same fashion as the first but complete coupling could be achieved in 2 hours at room 
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temperature followed by the acetylation and deprotection steps outlined above. Boc-Im-
OH (12) (241 mg, 1 mmol) was dissolved in 2 ml of NMP to which 360 mg (l mmol) of 
HBTU and 1 ml of DIEA was added for activation of this monomer. Coupling was 
allowed to proceed for 1.5 hours at room temperature followed by acetylation. The Boc-
1m residue was deprotected using a 50% TF AIDCM solution for 30 minutes at room 
temperature. The next residue, a-Fmoc-y-Boc-(R)-diaminobutyric acid (DAB A) (14) 
(660 mg, 1.5 mmol) was activated with HBTU (540 mg, 1.5 mmol) in 2 ml ofNMP and 1 
ml of DIEA. Coupling of this residue onto the resin took 2 hours at 37°C. After 
acetylation and treatment with 20% TFAlDCM for 30 minutes, the next Boc-Py-OBt was 
attached in exactly the same manner as the second residue. The terminal two imidazoles 
were added as an Imlm-OH dimer (3). 249 mg (1 mmol) of the Imlm-OH dimer (14) 
was activated with HBTU (360 mg, 1 mmol) in 2 ml of NMP and 1 ml of DIEA and 
allowed to couple overnight at room temperature. It should be noted that the progress of 
the stepwise couplings were all monitored by analytical HPLC. The resin was washed 
thoroughly with DMF, DCM, MeOH and Et20 then dried in vacuo. A 75 mg sample of 
dried resin was suspended in 2 ml of CH2Cl2 to which was added 2 ml of 2.0 M 
ethyl amine in THF. This cleavage mixture was placed in a 37°C oven and allowed to 
stand overnight In a sealed scintillation vial. The resin was filtered, the eluent 
concentrated in vacuo, then purified by reverse phase HPLC. ImlmPy-(R)H2Ny_ 
ImPyPyCONHCH 3 (1.9 mg, 2.2 /-lmol, 10.6% recovery) was recovered upon 
lyophilization of the appropriate fractions as a white powder; UV (H20) Amax 310 (52140); 
IH NMR (DMSO-d6 ) 8 11.02 (s, IH), 10.36 (s, IH), 10.10 (s, IH), 9.89 (s, IH), 9.71 (s, 
IH), 8.20 (m, lH), 7.98 (m, IH), 7.56 (s, IH), 7.52 (s, IH), 7.45 (d, lH, ] = 0.9 Hz), 7.25 
49 
(d, IH, J = 1.5 Hz), 7.23 (d, IH, J = 1.5 Hz), 7.15 (d, IH, J = 1.8 Hz), 7.11 (d, lH, J = 1.8 
Hz), 7.06 (d, IH, J = 0.9 Hz), 7.03 (d, IH, J = 1.8 Hz), 6.83 (d, IH, J = 1.8 Hz), 3.99 (s, 
3H), 3.98 (s, 3H), 3.96 (s, 3H), 3.83 (s, 3H), 3.80 (s, 3H), 3.78 (s, 3H), 3.17 (dd, 2H, J = 
6.6 Hz), 2.42 (m, 2H), 2.26 (m, IH), 1.99 (m, 2H), 1.62 (m, lH), 1.05 (t, 3H J = 6.6 Hz), 
MALDI-TOF-MS 866.5 (866.39 calc for [M+H] C'9H4SNI70/). 
ImlmPy-(Rt2Ny-ImPyPyCONH2 (3) (Fmoc/Rink Resin Route). ImlmPy-
(R)BOCHNy-ImPyPyCONH-Rink resin was generated by manual solid phase synthesis from 
Fmoc-Rink resin (0.6 mmol/g) using Fmoc-protected monomers as previously described 
(3). A sample of the polyamide resin (30 mg) was cleaved by treatment of 20% TFA in 
DCM at room temperature for 2 hours. After filtration the cleavage solution was 
concentrated in vacuo and purified by reverse phase HPLC as previously described (3). 
ImlmPy-(R)H2Ny-ImpyPyCONH2 (630 J..lg, 750 nmol, 4.2% recovery) was recovered upon 
lyophilization of the appropriate fractions as a white powder. Spectroscopic analysis 
confirmed this product was identical to 3 produced by the Oxime route. 
ImlmPy-(R)H2Ny-ImPypyCONHMe (4). A 35 mg sample of dried resin 15 was 
suspended in 2 ml of CH2Cl2 to which was added 2 ml of 2.0 M methylamine in THF. 
This cleavage mixture was placed in a 37°C oven and allowed to stand overnight in a 
sealed scintillation vial. The resin was filtered, the eluant concentrated in vacuo, then 
purified by reverse phase HPLC. ImlmPy-(R)H2NY-ImPyPyCONHCH, (850 J..lg, 996 nmol, 
8.9% recovery) was recovered upon lyophilization of the appropriate fractions as a white 
powder; UV (H20) Amax 310 (52140); IH NMR (DMSO-d(,) 8 11.01 (s, 1 H), 10.35 (s, 1 H), 
10.09 (s, IH), 9.90 (s, IH), 9.70 (s, IH), 8.19 (m, IH), 7.92(m, IH), 7.56 (s, IH), 7.51 (s, 
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IH), 7.45 (d, IH, J = 0.9 Hz), 7.25 (d, IH, J = 1.8 Hz), 7.23 (d, IH, J = 1.8 Hz), 7.16 (d, 
IH, J = 1.5 Hz), 7.10 (d, IH, J = 1.5 Hz), 7.05 (d, IH, J = 0.9 Hz), 7.03 (d, IH, J = 1.8 
Hz), 6.79 (d, IH, J = 1.8 Hz), 3.99 (s, 3H), 3.98 (s, 3H), 3.96 (s, 3H), 3.82 (s, 3H), 3.79 
(s, 3H), 3.77 (s, 3H), 2.66 (m, IH), 2.41 (m, 2H), 2.25 (m, IH), 1.98 (m, 2H), 1.62 (m, 
2H), MALDI-TOF-MS 852.5 (852.38 calc for [M+H] C'XH46NI70/). 
ImlmPy-(Rt2Ny-ImPyPyCONH2 (5). A 30 mg sample of dried resin 15 was 
placed into a pressure tolerant screw cap test tube, suspended in 4 ml of dry THF and 
cooled for 20 minutes in a -10°C icelbrine bath. Anhydrous NH, gas was bubble into the 
suspension at a steady rate for 30 minutes to generate a saturated ammonia solution. 1.5 
ml of a lO%v/v solution of DBU in CH1Ci1, cooled to -20°C was quickly added to the 
cleavage mixture and the tube immediately sealed. The cleavage was allowed to proceed 
in a shaker at 37°C for 72 hours. The mixture is filtered and concentrated in vacuo, then 
purified by reverse phase HPLC. ImlmPy-(Rt2Ny-ImPyPyCONH2 (330 Ilg, 390 nmol, 
4.1 % recovery) was recovered upon lyophilization of the appropriate fractions as a white 
powder; UV (H20) Ama, 310 (52140); IH NMR (DMSO-do) 8 10.65 (s, IH), 10.32 (s, 
IH), 10.20 (s, IH), 9.90 (s, IH), 9.75 (s, IH), 8.09 (bs, IH), 7.55 (s, 3H), 7.47 (s, IH), 
7.44 (s, IH), 7.25 (d, IH, J = 2.1 Hz), 7.21 (d, IH, J = 2.1 Hz), 7.19 (bs 2H), 7.11 (d, IH, 
J = 1.8 Hz), 7.05 (d, IH, J = 1.2 Hz), 6.98 (d, IH, J = 1.2 Hz), 6.83 (d, IH, J = 1.5 Hz), 
6.65 (d, IH, J = 1.2 Hz), 6.53 (d, IH, J = 2.4 Hz), 3.99 (s, 3H), 3.98 (s, 3H), 3.96 (s, 3H), 
3.82 (s, 3H), 3.79 (s, IH), 3.77 (s, 3H), 2.97 (m, IH), 1.96 (m, 2H), 1.43 (m, 2H), 
MALDI-TOF-MS 838.4 (838.35 calc for [M+H] C'7H-l-lNI70/). 
ImlmPy-(Rt2Ny-ImpypyC02H (6). A 35 mg sample of dried resin 15 was 
cleaved by treatment with 1 ml of H20, I ml DMF, and 75 III DBU (0.48 mmo!) at 37°C 
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for 60 hours. After filtration the cleavage solution was concentrated in vacuo and 
purified by reverse phase HPLC. ImImPy-(R)H2NY-ImPyPyC02H (294 I-lg, 350 nmol, 
3.1 % recovery) was recovered upon lyophilization of the appropriate fractions as a white 
powder; UV (np) Amax 310 (52140); IH NMR (DMSO-d6 ) () 12.67 (bs, 1H), 11.53 (s, 
IH), 10.88 (s, IH), 10.62 (s, IH), 10.43 (s, IH), 10.22 (s, IH), 8.83 (m, IH), 8.07 (s, IH), 
8.03 (s, IH), 7.96 (d, IH, J = 0.9 Hz), 7.93 (d, IH, J = 1.8 Hz), 7.76 (d, 1H, J = 0.9 Hz), 
7.75 (d, 1H, J = 1.8 Hz), 7.64 (d, 1H, J = 1.2 Hz), 7.57 (d, 1H, J = 1.2 Hz), 7.54 (d, IH, J 
= 1.8 Hz), 7.34 (d, 1H, J = 1.8 Hz), 4.50 (s, 3H), 4.50 (s, 3H), 4.47 (s, 3H), 4.34 (s, 3H), 
4.31 (s, 3H), 4.31 (s, 3H), 2.50 (m, 2H), 2.11 (m, 2H), 2.06 (m, 3H), MALDI-TOF-MS 
839.4 (839.34 calc for [M+H] C'7H.nN 160/). 
Quantitative DNase I Footprinting. As previously reported (16). 
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CHAPTER 4 
Inhibition of Major Groove DNA Binding bZIP Proteins by 
Positive Patch Polyamides 
The text of this chapter was taken in part from a publication coauthored with Ryan 
Bremer, Jason W. Szewczyk, and Prof Peter Dervan. 
(R.E. Bremer, N.R. Wurtz, J.W. Szewczyk & P.B. Dervan Bioorganic & Medicinal 
Chemistry., 2001, 9, 2093-2103.) 
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Abstract 
Cell permeable synthetic ligands that bind to predetermined DNA sequences offer 
a chemical approach to gene regulation provided inhibition of a broad range of DNA 
transcription factors can be achieved. DNA minor groove binding polyamides containing 
aminoalkyl substituents at the N-l of a single pyrrole residue display inhibitory effects 
for a bZIP proteins that bind exclusively in the DNA major groove. For major groove 
protein inhibition, specific protein-DNA contacts along the phosphate backbone were 
targeted with the positively charged dimethylamino substituent on the backbone of a 
minor groove binding hairpin. Remarkably, these polyamides bind DNA with enhanced 
affinity and uncompromised specificity when compared to polyamides with the 
amino alkyl moiety at the C-terminus. By adding bZIP transcription factors to the class of 
protein-DNA complexes that can be disrupted by minor groove binding ligands, these 
results may increase the functional utility of polyamides modified at the N-alkyl position 
as regulators of gene expression. 
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Introduction 
Hairpin polyamides containing pyrrole (Py), imidazole (1m) and hydroxypyrrole 
(Hp) amino acids are synthetic ligands that bind predetermined DNA sequences in the 
minor groove with affinities and specificities comparable to many DNA binding proteins 
(1, 2). Rules have been developed that allow for sequence specific recognition of the 
DNA minor groove by relating each Watson Crick base pair with a particular pairing of 
the aromatic Py, 1m and Hp rings (1-4). The crescent shaped polyamides bind in the 
minor groove of DNA with pairs of aromatic rings stacked against each other and the 
walls of the groove, allowing the backbone amide hydrogens and the substituents at the 
3-position of the Py, 1m and Hp residues to make specific contacts with the edges of the 
intact base pairs. An y-aminobutyric acid residue (y) connects the polyamide subunits in a 
"hairpin" motif that enhances affinity and unambiguously locks the desired ring pairings 
in register. 
A requirement for the general application of minor groove binding polyamides as 
regulators of gene transcription is motifs that can effectively inhibit all classes of DNA 
binding proteins, especially transcription factors which bind regulatory elements in gene 
promoter regions. Polyamides have been found to interfere with protein-DNA recognition 
in cases where contacts in the minor groove are important for protein-DNA binding 
affinity (2). Polyamides targeted to minor groove contacts of transcription factors Ets-l, 
LEF-l, and TBP inhibited DNA-binding of the each protein in mobility gel shift assays 
(5). In contrast, polyamides have been shown to bind simultaneously with some proteins 
such as bZIP protein, GCN4, that exclusively occupy the DNA major groove (6-8). The 
ubiquity of major groove contacts in protein:DNA recognition provides the impetus to 
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develop approaches for the inhibition of major groove proteins by DNA minor groove 
binding polyamides. 
Hairpin polyamides with the tripeptide Arg-Pro-Arg at the C-terminus have been 
shown to inhibit GCN4, a bZIP protein bound exclusively in the major groove, 
potentially by competing with the protein side chains for electrostatic contacts to the 
DNA phosphate backbone (8). However, Arg-Pro-Arg modified polyamides may be 
limited by the use of a-amino acids with regard to biostability. This lead us to ask the 
question of whether a N-aminoalkylpyrrole residue could serve as a simple nonpeptide 
substitute for the Arg-Pro-Arg tripeptide positive patch that can be placed at any position 
along the polyamide backbone that would allow for discrete targeting of phosphodiester 
protein contacts. 
Analysis of an X-ray crystal structure of a polyamide bound to its cognate DNA 
site reveals that the N-l substituent of each pyrrole ring makes its closest phosphate 
contact two phosphates to the 3' side of the base the ring pair recognizes, consistent with 
the minor groove binding nature of the polyamide (9). Polyamides displaying an N-
amino alkyl positive patch could interfere with protein binding to this specific phosphate 
and consequently inhibit specific contacts with DNA. The increasing availability of 
protein-DNA crystal structures provide the necessary information to design a polyamide 
that targets important protein:DNA contacts. Previous attempts to inhibit major groove 
binding transcription factors with minor groove binding ligands have used polyamine 
substituents with ten charges attached to a tripyrrole, likely resulting in a ligand with 
significantly reduced sequence specificity (l0). 
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Figure 4.1. Structures of eight-ring hairpin polyamides containing N-methylpyrrole residues and a C-
terminal Dp tail (top) and polyamides with N-aminoalkylpyrrole residues and a C-terminal N-methylamide. 
ImPyPyPy-y-PyPyPyPy-P-Dp (1), and ImPyPyPy-y-ImPyPyPy-p-Dp (2) (top). ImPyPyPy(Dp)-y-
PyPyPyPy-p-Me (3), ImPyPyPy(Dp)-y-ImPyPyPy-p-Me (4), ImPyPyPy(C30Dp)-y-PyPyPyPy-p-Me (5), 
ImPyPyPy(DpC30Me)-y-PyPyPyPy-p-Me (6), ImPyPyPy(DpDp)-y-PyPyPyPy-p-Me (7) and 
ImPyPyPy(DpDp)-y-ImPyPyPy-p-Me (8). 
We report here the synthesis and DNA binding properties of a series of hairpin 
polyamides containing N-aminoalkyl substitutions at a single pyrrole residue and their 
ability to inhibit DNA binding by a major groove binding protein, GCN4 (222-281), a 
member of the bZIP family of transcriptional activators. Analysis of the crystal structure 
of GCN4-DNA complex reveals a key Lys 246-DNA phosphate backbone contact (11). 
Polyamides were designed to place a positive charge at the crucial DNA phosphate 
Lys246 position to diminish a likely important electrostatic interaction. A series of 
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polyamides were synthesized that contain multiple amines and selected ether 
substitutions as controls on the N-1 position of the pyrrole. The DNA binding affinity and 
specificity of each of these compounds for their target sites was evaluated using 
quantitative DNase I footprinting and compared to analogs containing the traditional N-
methyl substituents. Gel mobility shift assays were employed to investigate the ability of 
these polyamides to inhibit DNA binding by a major groove binding protein. 
Results 
Polyamide Synthesis. The synthesis of N-aminoalkylpyrrole-containing 
polyamides 3-8 (Figure 1) required the preparation of a new pyrrole monomer suitable 
for solid phase synthesis and subsequent modification at the N -1 position. (3-
Hydroxypropyl)-4-[(tert-butoxycarbonyl)amino]-pyrrole-2-carboxylic acid, (11), 
introduces a 3-hydroxypropyl moiety at the N-1 of pyrrole which can be modified by 
sulfonylation followed by nucleophilic displacement to afford a variety of derivatives 
from a single polyamide precursor. By cleaving the polyamide from resin with 
methylamine, polyamides (3 and 4) can be obtained that are structural isomers of those 
previously reported (1 and 2) and limit the overall charge of the N-diaminoalkylpyrrole-
containing polyamides (7 and 8) (12). EthyI4-nitropyrrole-2-carboxylate (9) is available 
in 500 g quantities as described (13). Alkylation of the pyrrole N-l with 3-iodoproponol 
provided 10. Reduction and Boc protection of the amine followed by hydrolysis of the 
ethyl ester afforded 11 in gram quantities in 53% yield. (Figure 4.2) 
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ii, iii, iv.. ~OH 
HOj 0 
11 
Figure 4.2. Synthesis of the Boc-N-(3-hydroxypropyl)pyrrole-acid monomer (11) for solid phase synthesis. 
(i) Iodopropanol, acetone, K2C03• (ii) H2, to % PdJC, DMF. (iii) Boc-anhydride, DIEA. (iv) 1 M KOH, 
EtOH,70°C. 
The N-(3-hydroxypropyl)pyrrole monomer 11 was used without further protection 
in the Boc-chemistry machine assisted solid phase synthesis of polyamides 12 and 13 
from Boc-~-Ala-PAM resin (Figure 4.3) (14). In order to provide polyamides that differ 
from those previously reported only by the placement of the positively charged N,N-
dimethylaminopropyl moiety and the N-methyl group, it was necessary to cleave the 
polyamide from resin using methylamine. This was accomplished by condensing 
methylamine in a Parr apparatus with resin-bound polyamide, followed by heating 
overnight (55 DC) to provide crude polyamides ImPyPyPy(C30H)-y-PyPyPyPy-~-Me, 
(12), and ImPyPyPy(C30H)-y-ImPyPyPy-~-Me, (13), containing the N-(3-
hydroxypropyl)pyrrole residue suitable for further modification. The free hydroxyl of the 
crude polyamide was activated with p-toluenesulfonyl chloride or methanesulfonyl 
chloride in dry pyridine. Nucleophilic displacement of the tosylate or mesylate with the 
appropriate amine (3, 4, 6-8) or sodium salt (5) followed by preparatory reverse phase 
HPLC provided the desired N-aminoalkyl substituted polyamides in recoveries similar to 
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Figure 4.3. Synthetic scheme for solid phase preparation of N-aminoalkylpyrrole containing polyamides 
(15). Cycling protocols consisted of trifluoroacetic acid (TFA) deprotection followed by coupling with 
HOBt-activated Boc-pyrrole, Boc-imidazole, Boc-N-(3-hydroxypropyl)pyrrole (11) or aliphatic amino acid 
ester. (i) The PAM resin is then cleaved by treatment with methylamine. (ii) Activation with 
methanesulfonyl chloride or toluenesulfonyl chloride followed by reaction with the appropriate amine or 
alkoxide (iii) and reverse phase HPLC provided the desired products. The synthesis of ImPyPyPy(DpDp)-
y-PyPyPyPy-~-Me (7) is shown as a representative example. 
Quantitative DNase I footprint titrations. The DNA binding affinity and 
specificity for the six base pair target sites were measured for the N-aminoalkylpyrrole-
containing polyamides by quantitative DNase I footprinting on the 229-bp AJlIIIFspI 
restriction fragment of pJTS (12). Polyamides of the basic composition ImPyPyPy-y-
ImPyPyPy (2,4 and 8) were designed to bind the site 5'-AGTACT-3' according to the 
pairing rules. Conversely, the single atomic substitution that converts an imidazole to a 
pyrrole residue provides polyamides based on ImPyPyPy-y-PyPyPyPy (1,3 and 5-7), 
targeted to 5'-AGTATT-3'. The sites 5'-AGTACT-3' and 5'-AGTATT-3' are for 
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ImPyPyPy-y-ImPypyPy polyamides "match" and "single base pair mismatch" sites, 
respectively, and for ImPyPyPy-y-PyPyPyPy polyamides "single base pair mismatch" 
and "match" sites, respectively. 
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Figure 4.4. Storage phosphor autoradiograms of quantitative DNase I footprint titration experiments with 
(A) ImPyPyPy(Dp)-y-ImPyPyPy-j3-Dp (4) and (B) ImPyPypy(DpDp)-y-ImPyPyPy-j3-Dp (8) on the 3'_32p_ 
end-labeled AfllVFspI restriction fragment from pJTS (13)" All reactions contained S kcpm restriction 
fragment, 10 mM Tris-HCI (pH 7,,0), 10 mM KCI, 10 mM MgCI2 and 5 mM CaCI2 and were performed at 
22 0c.. Lane 1, intact DNA; lane 2, A-specific reaction; lane 3, G-specific reaction; lane 4, DNase I 
standard; lanes 5-21,100 fM, 200 fM, 500 fM, I pM, 1..5 pM, 2.5 pM, 4.0 pM, 6.5 pM, 10 pM, 15 pM, 25 
pM, 40 pM, 65 pM, 100 pM, 200 pM, 500 pM, 1 nM, respectively of 3 or 8. The 65 pM lane has been 
omitted for 8. The positions of the match (5'-AGTACT-3') and single base pair mismatch (5'-AGTAIT-3') 
sites are indicated. 
DNase I footprinting revealed that ImPyPyPy(Dp)-y-ImPyPyPy-~-Me (4) bound 
the 5'-AGTACT-3' with an equilibrium association constant Ka = 1.9 (±0.4) x 1011 M"l, 
and a 56-fold preference over the single base pair mismatch site (Ka=3.3 (±0.4) x 109 M1) 
(Figure 4.4A, Table 4.1). This represents ::::lO-fold increase in affinity relative to the 
parent polyamide differing in the placement of the dimethylaminopropyl and N-methyl 
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moieties, ImPyPyPy-y-ImPyPyPy-~-Dp (2) (Ka=1.4 (±0.5) x 1010 M- I for 5'-AGTACT-
3'), and uncompromised specificity (6l-fold, Ka=2.3 (±0.5) X 108 M-1 for 5'-AGTAIT-3'). 
The increase in affinity upon placement of the alkylamine on the pyrrole ring was also 
observed for ImPyPyPy(Dp)-y-PyPyPyPy-~-Me (3) relative to ImPyPyPy-y-PyPyPyPy-
~-Dp (1). Polyamide 3 bound the 5'-AGTATT-3' match site with an affinity Ka = 1.3 
(±0.6) x 1010 M- I and a 4-fold preference over the single base pair mismatch site (Ka=2.9 
(±0.6) x 109 M- 1). In comparison, the parent polyamide, 1, bound both the match and 
mismatch sites with reduced affinity (Ka=1.5 (±0.3) x 109 M- I for 5'-AGTATT-3' and 
Ka=2.4 (±1.2) X 108 M- I for 5'-AGTACT-3'). 
In order to explore the potential applications of amino alkyl substitutions of the 
pyrrole ring, the DNA binding affinities and specificities of analogs containing multiple 
amines or selected ether linkages were determined. The presence of an additional 
aminopropyl moiety to provide a polyamide with potentially two positive charges, as in 
ImPyPyPy(DpDp)-y-ImPyPyPy-~-Me (8), resulted in an additional slight increase in 
affinity for the match site relative to 4 (Ka=3.0 (±0.4) x lOll M- 1), and a 36-fold 
preference over the mismatch site (Ka=8.2 (±3.1) x 109 M- 1) (Figure 4.4B, Table 4.1). 
This represents only a modest decrease in specificity for 8 relative to 4 (36-fold and 56-
fold, respectively). A similar decrease in specificity was observed for ImPyPyPy(DpDp)-
y-PyPyPyPy-j3-Me (7) relative to polyamide 3 (Ka=6.9 (±1.2) x 10
9 M- I for 5'-AGTATT-
3' and Ka=3.l (±1.0) X 109 M- I for 5'-AGTACT-3'). Substitution of either tertiary amine in 
7 to provide the singly charged polyamides ImPyPyPy(C30Dp)-y-PyPyPyPy-~-Me (5) 
and ImPyPyPy(DpC30Me)-y-PyPyPyPy-~-Me (6) restored the optimal affinity and 
specificity observed with 3, while retaining the overall size and length of 7. Polyamide 5, 
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containing an internal ether linkage and a terminal dimethylamine, bound the 5'-
AGTATT-3' match site with a Ka = 1.2 (±0.1) x 1010 M- l with a 7-fold preference over 
the 5'-AGTACT-3' mismatch (1.8 (±0.9) x 109 M- l ). Similarly, the introduction of an 
internal amine and a terminal methyl ether in 6 resulted in Ka = 1.5 (±0.3) x 1010 M- l and 
2.2 (±0.7) x 109 M- l for the match and mismatch sites, respectively. 











1.5 X 109 (± 0.3) 
1.3 x 1010 (± 0.6) 
1.4 x 1010 (± 0.5) 
1.9 x 1011 (± 0.4) 
1.2 x 1010 (± 0.1) 
1.5 x 1010 (± 0.3) 
6.9 x 109 (± 1.2) 
3.0 x 1011 (± 0.4) 
Mismatch 
2.4 X 108 (± 1.2) 
2.9 x 109 (± 0.6) 
2.3x 108 (± 0.5) 
3.3 x 109 (± 0.4) 
1.8 x 109 (± 0.9) 
2.2 x 109 (± 0.7) 
3.1 x 109 (± 1.0) 
8.2 x 109 (± 0.4) 
aValues reported are the mean values obtained from at least three DNase I footprint titration experiments. 
The assays were carried out at 22° C, 10 mM Tris'HCI (pH 7.0), 10 mM KCI, 10 mM MgCI2' and 5 mM 
CaCI
2
• The match and mismatch sites for 1, 3 and 5-7 are 5'-ttAGTATTtg-3' and 5'-ttAGTAC.Ttg-3', 
respectively. The match and mismatch sites for 2, 4 and 8 are 5'-ttAGTACTtg-3' and 5'-ttAGTAITtg-3', 
respectively. 
Protein Binding Inhibition by Polyamides determined by Gel Shift. The 
ability of N-aminoalkylpyrrole-containing polyamides to inhibit DNA binding by GCN4 
(222-281) was investigated using gel mobility shift assays. The carboxy-terminal 60 
amino acids of GCN4 (222-281) contain the "leucine zipper" dimerization domain and 
the basic region DNA binding domain and have been shown to be sufficient for sequence 
specific DNA binding (15, 16). GCN4 (222-281) binds its target site as a dimer of u-
helices that make specific hydrogen bonds, van der Waal contacts and phosphate 
interactions in the DNA major groove (Figure 4A,B) (11, 17). Gel mobility shift assays 
were performed as previously described (6, 8, 16). 
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Figure 4.5. A schematic model of N-(aminoalkyl)pyrrole polyamides targeted to the major groove 
transcription factor, GCN4. (A) The a-helical GCN4 dimer is shown binding to adjacent major grooves 
(II). The N-(aminoalkyl)pyrrole polyamide is shown as black and white balls, which represent imidazole 
and pyrrole amino acids, respectively. The diamond represents l3-alanine; y-aminobutyric acid is designated 
as a curved line and the amino alkyl chain is represented by a plus sign in a circle. (B) The contacts between 
one GCN4 monomer and the major groove of one half-site of S'-CTGACTAAT-3' are depicted (adapted 
from Ref. #11). Circles with two dots represent the lone pairs of the N7 of purines, the 04 of thymine, and 
the 06 of guanine. Circles containing an H represent the N6 and N4 hydrogens of the exocyclic amines of 
adenine and cytosine, respectively. The CS methyl group of thymine is depicted as a circle with CH3 inside. 
Plus signs represent protein residues, which electrostatically contact the phosphate backbone. (C) The 
hydrogen bonding model of the eight-ring hairpin polyamide ImPyPyPy(DpDp)-y-PyPyPyPy-I3-Me bound 
to the minor groove of S'-AGTAAT-3'. Circles with two dots represent the lone pairs of N3 of purines and 
02 of pyrimidines. Circles containing an H represent the N2 hydrogens of guanines. Putative hydrogen 
bonds are illustrated by dotted lines. (D) The model of the polyamide binding its target site (bold) adjacent 
to the GCN4 binding site (brackets). Polyamide residues are as in A. 
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The polyamides of the sequence ImPyPyPy-y-PyPyPyPy were designed to bind 
the 5'-AGTAAT-3' site adjacent to the GCN4 binding site (5'-CTGACTAAT-3') on the 
synthetic DNA duplex ARE-4. Aminoalkyl substitutions at the N-I of the Py residue 
immediately to the N-terminal side of the y-tum were designed to target the phosphate of 
the 3'-TpT-5' step (Figure 4.5). Incubation of the radiolabeled DNA fragment with the 
parent N-methyl containing polyamide ImPyPyPy-y-PyPyPyPy-~-Dp (1) resulted in only 
a slight inhibition of protein binding, supporting our earlier observation that standard 
Py/Im polyamides bind simultaneously with major groove binding bZIP proteins (Figure 
4.6A). The placement of N', N'-dimethylaminopropyl at the N-l position of the specified 
pyrrole in 3 did not offer a significant improvement in GCN4 (222-281) inhibition over 1 
(Figure 4.6B). However, incorporation of a second positive charge and a longer tether, as 
in 7, provided 54% inhibition of GCN4 binding (Figure 4.6C, 4.7). The specificity of 
GCN4 inhibition was also tested using ImPyPyPy(DpDp)-y-ImPyPyPy-~-Me (8), which 
is a single base pair mismatch for the polyamide site on ARE-4 and binds the DNA with 
significantly reduced affinity relative to 7. Indeed, controls reveal that single mismatch 
polyamide 8 did not inhibit GCN4 binding (Figure 4.6D). 
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Figure 4.6. GCN4 (222-281) gel mobility shift experiments in the presence of N-methylpyrrole and N-
aminoalkylpyrrole polyamides. (A-F) Top, model of polyamide binding the DNA fragment ARE-4. 
Mismatches are indicated by a grey box. Bottom, storage phosphor autoradiogram of non-denaturing 
polyacrylamide gel showing GCN4 (222-281) binding to the radiolabeled ARE-4 fragment in the presence 
of increasing concentrations of polyamide (10 mM bisTris pH 7.0, 100 mM NaCI, I mM DTT, I mM 
EDTA, 50 /J-g/mL poly(dI-dC)·poly(dI-dC), 22 °C). The upper band is the GCN4 (222-28 I)-DNA complex 
and the lower band is free DNA. Lane 1 is DNA only. Lane 2 contains DNA incubated with 200 nM GCN4 
(222-281). Lanes 3-14 are 200 nM GCN4 (222-281) and 100 pM, 200 pM, 500 pM, I nM, 2 nM, 5 nM, 10 
nM, 20 nM, 50 nM, 100 nM, 200 nM, and 500 nM polyamide: (A) ImPyPyPy-y-PyPyPyPy-P-Dp (1), (B) 
ImPyPyPy(Dp)-y-PyPyPyPy-p-Me (3), (C) ImPyPyPy(DpDp)-y-PyPyPyPy-p-Me (7), (D) 
ImPyPyPy(DpDp)-y-ImPyPyPy-p-Me (8), (E) ImPyPyPy(C30Dp)-y-ImPyPyPy-p-Me (5), (F) 
ImPyPyPy(DpCpMe)-y-ImPyPyPy-p-Me (6). 
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Optimal GCN4 Inhibition Requires N-diaminoalkylpyrrole. It was important 
to determine if the basis for GCN4 inhibition by 7 was dependent upon the presence of 
either potentially charged amines or if perhaps the added length of the second 
aminopropyl was sufficient for inhibition. Polyamide 5 contains an ether linkage in place 
of the internal amine in 7, resulting in a single charge placed distal to the polyamide. This 
change was sufficient to abolish GCN4 inhibition (Figure 4.6E). Furthermore, 6, 
containing a single charge internal and a terminal methyl ether, exhibited similar 
behavior with only slight inhibition on GCN4 binding (Figure 4.6F). These results 
combined suggest that both of the positive charges present in 7 are necessary for 
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Figure 4.7. The level of GCN4 inhibition achieved by selected polyamides is compared. For each 
concentration of polyamide, the fraction of bound probe was determined by phosphorimager analysis 
followed by dividing the signal of the bound band by the sum of the bound and free bands. This value was 
normalized across experiments by dividing the value for each concentration by that for a control lane on the 
gel performed only with GCN4 (222-281). Typically, the fraction of bound probe in the absence of 
polyamide was ",,0.70. The optimal GCN4 inhibition observed for 7 is depicted with triangles. The slight 
inhibition provided by 1 and 3 is shown as unfilled and filled circles, respectively. The absence of 
inhibition with 8 is depicted with squares. 
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Directing the Positive Patch to Adjacent Phosphates. To ask whether GCN4 
binding inhibition by polyamide 7 was specific for a particular phosphate residue, DNA 
probes were designed to shift the polyamide binding site by one or two base pairs relative 
to that in ARE-4. It was necessary to not alter the DNA sequence of the protein binding 
site in this new design. To accomplish this, the AfT-tract at the 3' side of the GCN4 
binding site and the degeneracy of PylPy pairs for A·T and T·A base pairs was exploited. 
By simply shifting the G·C bp bound by the polyamide to the 3' or 5' side, probes were 
obtained that would deliver the polyamide positive patch to a different phosphate on the 
DNA backbone. ARE-3 and ARE-6 shift the polyamide to one or two base pairs deeper 
into the GCN4 binding site, respectively, while ARE-5 moves the polyamide one bp 
distal to the GCN4 cognate sequence, relative to ARE-4. Significant inhibition of GCN4 
to any of these probes was not obtained at concentrations of 7 up to 20 times higher than 
that required for the maximum inhibition of GCN4 on ARE-4 (Figure 4.8). On ARE-3, 7 
showed a slight amount of GCN4 inhibition (Figure 4.8C), while an apparent 
enhancement in GCN4 binding was observed on ARE-5 with as little as 100 nM 7 
(Figure 4.8A). This study reveals that specific targeting of a protein-DNA contact is 





5' -G C T G ACT A A ~ T-3' 5' -G C T G ACT A ~ A T-3' 
















5'-G C T G ACT ~ T A T-3' 5'-G ' C T G A C ~ T T A T-3' 
3'-C , G ACT GA T T A,A G A A T A-5' 3'-C,G ACT G AT T A,G A A A T A-5' 
o 
-=========n -=========n 
GCN4 (226-281) I GCN4 (226-281) I 
2345678 2345678 - - GCN4-DNA 
DNA _ 
71 
Figure 4.8. The effect of moving the polyamjde bindjng site on GCN4 inhibition is investigated. Results 
are presented as in Figure 6. All panels include Lane 1: DNA only, Lane 2: 200 nM GCN4(222-28 I), Lane 
3-8: 100 pM, 1 nM, 10 nM, 100 nM, 111M, and 10 11M 7, respectively. (A) ARE-5 probe, (B) AREA 
probe, (C) ARE-3 probe, (D) ARE-6 probe. 
Discussion 
A Py(Dp) Residue Increases Polyamide Affinity without Compromising 
Specificity_ Generally, Py/Im polyamides are prepared using N-methyl aromatic amino 
acids and a dimethyalaminopropylamide tail on the C-terminus as in 1 and 2. Exchanging 
the placement of the Dp and N-Me to provide a polyamide with a N-(N', N'-
dimethylaminopropyl)pyrrole residue and a C-terminal N-methyl amide (3 and 4) affords 
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an isomer of identical molecular weight and composition; however, affinity for the DNA 
cognate site is increased IO-fold without compromising specificity at least in this case. 
The affinity enhancement observed may result from a specific interaction between the 
positively charged side chain and the phosphate oxygen or more likely relief of 
unfavorable steric interactions of the dimethylaminopropyl tail at the C-terminus clashing 
with the floor of the minor groove. As the generality of the pairing rules are explored for 
the sequence specific recognition of DNA, the incorporation of N-aminoalkylpyrrole 
residues to increase affinity may be useful for DNA sequences that otherwise cannot be 
targeted with subnanomolar affinity (18). 
N-diaminoalkylpyrrole Polyamides Inhibit DNA Binding by GCN4. The 
incorporation of a doubly positively charged alkyl chain on the N-I of a pyrrole residue 
has afforded a new class of hairpin polyamides that can effectively inhibit DNA binding 
by an exclusively major groove binding bZIP protein. The presence of the positive patch 
is designed to compete with protein side chains that make electrostatic contacts to the 
phosphate backbone, potentially by partially neutralizing the negative charge of the 
phosphate. The maximal GCN4 inhibition achieved with 7 is equivalent to that of the 
Arg-Pro-Arg analog; however, it is observed at lO-fold lower polyamide concentration 
for 7 than for the Arg-Pro-Arg polyamide (8). Furthermore, the N-diaminoalkyl moiety 
could be delivered from any ring in the polyamide, providing a versatility in design that 
allows for a polyamide target site optimized for recognition to be combined with the 
positive patch, offering a greater number of targetable major groove proteins. 
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The optimal location of the positive patch for GCN4 inhibition is consistent with 
X-ray crystal structure data and phosphate ethylation interference experiments (11, 19). 
As described above, the positive patch of the polyamide on ARE-4 is likely directed to 
the phosphate of the 3'-TpT-5' step. X-ray crystallography of GCN4 bound to a different 
DNA sequence reveals the residue Lys246 makes an electrostatic contact to the 
corresponding phosphate. Ethylation at the analogous phosphate on another GCN4 
binding site resulted in a severe loss in affinity of GCN4 for the DNA target (19). While 
structural studies show other electrostatic contacts between protein side chains and the 
phosphates on either side of the 3'-TpT-5' step, ethylation of these phosphates has less of 
an effect on GCN4 binding affinity (11, 19). This latter observation is consistent with a 
lack of significant inhibition for 7 on ARE-3 and ARE-5. The slight inhibition observed 
for ARE-3 may be due to the flexible linker of 7 interacting with the 3'-TpT-5' step 
shown to inhibit GCN4 binding. Ethylation of the phosphate corresponding to the 3'-
GpT -5' (ARE-6) reduced GCN4 affinity; however, no protein contacts to this phosphate 
have been identified by crystallography (11, 19). Taken together, these results suggest 
that the inhibition of a given protein:phosphate contact may not be universally equivalent 
in its effect on protein binding. Each contact plays a unique role in DNA recognition and 
inhibition of protein binding by positive patch polyamides may need to be optimized for 
each application. 
The inability of polyamides containing ether linkages in place of the amines in 7 
(5 and 6) to effectively inhibit GCN4 binding demonstrates at a minimum that an alkyl 
chain of this length is insufficient to obtain protein inhibition and that the amine nitrogens 
place a specific role in inhibiting GCN4 binding. The amines may be partially 
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neutralizing one or more phosphates to interfere with a protein:DNA contact or 
potentially distort the DNA by phosphate neutralization (20). Perhaps the strongest 
evidence for a specific phosphate contact comes from the protein inhibition data. It is not 
clear how the GCN4 inhibition by N-aminoalkylpyrrole polyamides could be explained 
in light of the previously discussed phosphate ethylation data in the absence of a specific 
polyamide:phosphate contact that partially neutralizes the negative charge of the 
phosphate. Modeling suggests that the diamino ligand does not possess the necessary 
length to significantly block the DNA major groove. If the protein were inhibited simply 
by steric bulk extending into the major groove, one would have expected 5 and/or 6 to 
effectively inhibit the protein. Furthermore, the lack of inhibition provided by the 
mismatched polyamide 8 demonstrates that the mechanism of inhibition requires a 
polyamide specifically bound in the minor groove. 
Conclusions 
A new class of hairpin polyamides containing a positively charged alkyl amine at 
the N-l of a pyrrole ring have been shown to sequence specifically recognize DNA with 
high affinity and specificity relative to analogs with the amine at the C-terminus. The 
positive patch provided by a N-diaminoalkylpyrrole residue proved reasonably effective 
in the inhibition of DNA binding by the major groove binding protein GCN4 (222-281), 
potentially by competing with the protein side chains for electrostatic contacts to the 
DNA phosphate backbone. However, there remains room for improvement if we consider 
this series to be a first generation design. Nevertheless, these positive patch polyamides 
may expand the functional repertoire of polyamides for use in chemical genetics. 
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Experimental 
All synthetic reagents were as previously described or obtained from Aldrich (14). 
Analytical HPLC was performed on a Beckman Gold Nouveau system with a model 126 
pump and model 168 diode array detector. A Rainen C 18, Microsorb MV, 5 ~m, 300 x 4.6 
mm reverse phase column was employed with 0.1% (w/v) TFA:H20 and 1.5% 
acetonitrile/min. Preparatory HPLC was performed on a Waters DeltaPak 25 x 100 mm 
100 ~m C I8 column in 0.1 % (w/v) TFA, gradient elution 0.25%/min. CH3CN. Resin 
substitution of synthesized polyamides was calculated as Lnew(mmol/g) = Lo1i(l + 
LoliWnew - Wold) x 10-3) where L is the loading (mmol of amine per gram of resin) and W 
is the weight (g morl) of the growing peptide attached to the resin (14). DNA restriction 
fragment labeling, DNase I footprinting, and determination of equilibrium association 
constants were accomplished using previously described protocols (21, 22). Chemical 
sequencing reactions were performed according to published methods (23,24). 
Monomer Synthesis 
Ethyl (3-hydroxypropyl)-4-nitropyrrole-2-carboxylate (10). Potassium carbonate 
(22.8 g, 163 mmol) was added to ethyl 4-nitropyrrole-2-carboxylate (9) (10 g, 54.3 
mmol) in acetone (740 mL) and the slurry stirred for 2 hours, followed by the addition of 
3-iodopropanol (23.5 g, 109 mmol) and refIuxing for 2 hours. The reaction was cooled to 
room temperature, filtered and concentrated in vacuo. Water (200 mL) was added to the 
resulting oil, the pH of the aqueous layer was reduced to 3 with 10% H2S04, and the 
mixture extracted with ethyl acetate. The combined ethyl acetate extracts were dried 
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(MgS04) and concentrated in vacuo. The solid was chromatographed with silica gel 
(ethyl acetate:hexanes) to provide a clear oil 02.8 g, 52.6 mmol, 99% yield): IH NMR 
(DMSO-d6 ): 8 8.21 (s, IH), 7.32 (s, IH), 4.62 (t, IH, 1=4.9 Hz), 4.47 (t, 2H, 1=6.8 Hz), 
4.21 (q, 2H, 1=7.0 Hz), 3.31 (q, 2H, 1=6.1 Hz), 1.80 (m, 2H), 1.30 (t, 3H, 1=7.0 Hz). 
(3-Hydroxypropyl )-4-[ (tert-butoxycarbonyl)amino] -pyrrole-2-carboxylic acid (11). 
Ethyl (3-hydroxypropyl)-4-nitropyrrole-2-carboxylate (6.08 g, 25.1 mmol) was dissolved 
in DMF (20 mL). 10% Pd/C (1.0 g) was added and the mixture was stirred under 
hydrogen (300 psi) for 3 hours. Pd/C was removed by filtering through Celite. Di-tert-
butyl dicarbonate (5.41 g, 24.8 mmol) and DIEA (8.6 mL, 50 mmol) was added and 
stirred for 2 hours. The reaction was cooled to room temperature, filtered, washed with 
methanol and concentrated in vacuo. Chromatography with silica gel (ethyl 
acetate:hexanes) provided a clear oil (5.10 g, 16.3 mmol, 65% yield): IH NMR (DMSO-
d6 ): 89.08 (s, IH), 7.06 (s, IH), 6.60 (s, IH), 4.49 (t, 1H, 1=5.1 Hz), 4.20 (t, 2H, 1=6.8 
Hz), 4.12 (q, 2H, 1=7.5 Hz), 3.30 (q, 2H, 1=5.5 Hz), 1.72 (m, 2H), 1.45 (s, 9H), 1.23 (t, 
3H, 1=7.5 Hz). Ethyl (3-hydroxypropyl)-4-[(tert-butoycarbonyl)amino]-pyrrole-2-
carboxylate (2.0 g, 6.4 mmol) was dissolved in ethanol 00 mL), followed by the addition 
of 1M KOH (40 mL) and heating (70 °C) for 2 hours. The reaction was cooled to room 
temperature and washed with ethyl ether. The pH of the aqueous layer was reduced to 3 
with 10% H2S04, and the mixture extracted with diethy1 ether. The combined ethyl 
acetate extracts were dried (MgS04) and concentrated in vacuo to provide a white, 
crystalline solid 0.5 g, 5.3 mmol, 83% yield): IH NMR (DMSO-d6 ): 8 12.04 (s, 1H), 9.05 
(s, 1H), 7.04 (s, 1H), 6.54 (s, 1H), 4.20 (t, 2H, 1=6.8 Hz), 3.27 (q, 2H, 1=6.1 Hz), 1.73 (m, 




resin was synthesized in a stepwise fashion by machine-assisted solid phase methods 
from Boc-~-PAM-resin (600 mg, 0.75 mmol/g). (3-hydroxylpropyl)-4-[(tert-
butoxycarbonyl)amino]-pyrrole-2-carboxylic acid (212 mg, 0.75 mmol), HBTU (284 mg, 
0.75 mmol) and HOBt (304 mg, 2.25 mmol) were added dry to a synthesis cartridge. 
Upon delivery of DMF and DIEA activation occurs as described. A sample of polyamide 
resin (380 mg, 0.43 mmol/g) was cleaved with methylamine (55°C, 28 hr.) in a Parr 
apparatus. The methylamine was allowed to evaporate and the crude polyamide was 
redissolved in 1: 1 1M NH40H:CH3CN (20 mL), filtered to remove the resin and 
lyophilized dry (146 ~mol). 
ImPyPyPy(C30H)-'Y-ImPyPyPy-~-Me (13). ImPyPyPy(C30H)-y-ImPyPyPy-~-PAM-
resin was synthesized in a stepwise fashion by machine-assisted solid phase methods 
from Boc-~-PAM-resin (450mg, 0.75 mmol/g) as described above. A sample of 
polyamide resin (178 mg, 0.43 mmollg) was cleaved with methylamine (55°C, 18 hr.) in 
a Parr apparatus. The methylamine was allowed to evaporate and the crude polyamide 
was redissolved in 1: 1 1M NH40H:CH3CN (20 mL), filtered to remove the resin and 
lyophilized dry (56 ~mol). 
ImPyPyPy(Dp)-'Y-ImPyPyPy-~-Me (3). Crude ImPyPyPy(C30H)-y-ImpypyPy-(3-Me 
(25 ~mol) was dissolved in pyridine (600 ~L) followed by the addition of 
methanesulfonyl chloride (100 ~L). After 30 min., the reaction was precipitated with 
ethyl ether (1 mL), decanted, and redissolved in DMF (1 mL). 1:1 Dimethylamine (2.0M 
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in THF):DMF (3 mL) was added and the reaction allowed to proceed for 45 min. at 90 
°C. The reaction was diluted to 8 mL with 0.1% (w/v) TFA and purified by preparatory 
reverse phase HPLC to afford ImPyPyPy(Dp)-y-ImPyPyPy-f3-Me (3) upon lyophilization 
of the appropriate fractions (1.3 mg, 1.0 J...lmol, 4.0 % recovery); UV (H20) Amax 312 
(66,000); IH NMR (DMSO-d6 ): 8 10.45 (s, IH), 10.27 (s, IH), 9.95 (s, 3H), 9.93 (s, IH), 
9.88 (s, IH), 9.27 (m, IH), 8.19 (m, IH), 8.00 (m, IH), 7.79 (m, IH), 7.42 (s, IH), 7.36 
(s, IH), 7.30 (s, IH,), 7.25 (s, IH), 7.22 (s, IH), 7.19 (s, IH), 7.15 (s, IH), 7.13 (s, 1H), 
7.10 (s, IH), 7.05 (s, IH), 7.00 (s, 2H), 6.87 (s, IH), 6.78 (s, IH), 4.26 (m, 2H), 3.94 (s, 
3H), 3.91 (s, 3H), 3.80 (s, 12H), 3.75 (s, 3H), 3.35 (m, 2H), 3.20 (m, 2H), 2.97 (m, 2H), 
2.74 (d, 6H, 1=4.8 Hz), 2.52 (d, 3H, 1=4.5 Hz), 2.29 (m, 4H), 2.02 (m, 2H), 1.75 (m, 2H); 
MS (MALDI-TOF): [M+Ht 1222.6, [M+Nat 1244.5, [M+Kt 1260.5. (Cs8HnN2101O+' 
[M+Ht, calc. 1222.6; CS8H71N21NaOIO+' [M+Nat, calc. 1244.6; CS8H71KN2101O+' [M+Kt, 
calc. 1260.5). 
ImpyPyPy(Dp)-Y-PyPyPYPy-p-Me (4). Crude ImPyPyPy(C30H)-y-PyPyPyPy-f3-Me 
(49 J...lmol) was dissolved in pyridine followed by the addition of toluene sulfonyl chloride 
(2.2 M in pyridine, 350 J...lL) and kept at 0 °C for 10 hours. After the addition of 
dimethylamine (2.0 M in THF, 2.0 mL), the reaction was heated at increasing 
temperatures until it was determined complete by analytical HPLC after 5 hours at 80°C. 
The reaction mixture was diluted to 8 mL with 0.1 % (w/v) TFA and purified by 
preparatory reverse phase HPLC to provide ImPyPyPy(Dp)-y-PyPyPyPy-f3-Me (4) upon 
lyophilization of the appropriate fractions (5.8 mg, 4.8 j..lmol, 9.8% recovery); UV (H20) 
Amax 312 (66,000); IH NMR (DMSO-d6 ): 8 10.46 (s, IH), 9.96 (s, IH), 9.95 (s, IH), 9.92 
(s, IH), 9.89 (s, IH), 9.88 (s, IH), 9.83 (s, IH), 9.2 (br s, IH), 8.18 (m, IH), 7.99 (m, 
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IH), 7.80 (m, IH), 7.38 (s, IH), 7.31 (d, IH, J=1.8 Hz), 7.26 (d, IH, J=1.8 Hz), 7.20 (d, 
IH, J=1.5 Hz), 7.16 (m, 3H), 7.06 (d, IH, J=1.8 Hz), 7.03 (s, IH), 7.02 (s, IH), 7.01 (s, 
IH), 6.89 (d, IH, J=1.5 Hz), 6.84 (d, IH, J=1.5 Hz), 6.79 (d, IH, J=1.5 Hz), 4.24 (m, 2H), 
3.96 (s, 3H), 3.82 (s, 9H), 3.81 (s, 3H), 3.80 (s, 3H), 3.76 (s, 3H), 3.35 (m, 2H), 3.20 (m, 
2H), 3.00 (m, 2H), 2.74 (d, 6H, J=5.1 Hz), 2.53 (d, 3H, J=4.5 Hz), 2.27 (m, 2H), 2.03 (m, 
2H), 1.97 (m, 2H), 1.78 (m, 2H); MS (MALDI-TOF): [M+Ht 1221.6. (Cs9H73N20010+' 
[M+Ht, calc. 1221.6). 
ImPyPyPy(C30Dp)-y-PyPyPyPy-f}-Me (5). Crude ImPyPyPy(C30H)-y-PyPyPyPy-P-
Me (24 Ilmol) in pyridine (0.4 mL) at 0 °C was activated with MsCI (75 ilL) at 0° C for 
three hours, followed by precipitation with ether (I mL). The supernatant was redissolved 
in DMF (0.5 mL) and cooled to 0° C. N,N-dimethyl-3-amino-propanol (14 ilL, 120 Ilmol) 
was added to NaH (60% dispersion in mineral oil, 4.7 mg, 114 Ilmol) in DMF (150 ilL) 
and added to the reaction. Repeating the addition of NaH and N,N-dimethyl-3-amino-
propanol and warming to room temperature did not provide sufficient reaction after 27 
hours as determined by analytical HPLC. More NaH (60% dispersion in mineral oil, 60 
mg, 1.5 mmol) and N,N-dimethyl-3-amino-propanol (180 ilL, 1.5 mmol) was added, 
followed by reaction at room temperature for 22 hours. The reaction mixture was diluted 
to 8 mL with 0.1% (w/v) TFA and purified by preparatory reverse phase HPLC to afford 
ImPyPyPy(C30Dp)-y-PyPyPyPy-13-Me (5) upon lyophilization of the appropriate 
fractions (1.4 mg, 1.1 Ilmol, 4.6 % recovery); UV (H20) Amax 312 (66,000); IH NMR 
(DMSO-d6 ): b 10.43 (s, IH), 9.94 (s, IH), 9.93 (s, IH), 9.90 (s, IH), 9.87 (s, 2H), 9.81 (s, 
IH), 9.25 (m, IH), 8.16 (m, IH), 7.97 (m, IH), 7.77 (m, IH), 7.35 (s, IH), 7.32 (s, IH), 
7.30 (s, IH,), 7.24 (s, IH), 7.18 (s, 3H), 7.14 (s, IH), 7.13 (s, 2H), 7.05 (s, IH), 7.00 (s, 
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2H), 6.88 (s, IH), 6.82 (s, IH), 6.77 (s, IH), 4.25 (m, 2H), 3.94 (s, 3H), 3.80 (s, 15H), 
3.75 (s, 3H), 3.34 (m, 4H), 3.20 (m, 2H), 3.00 (m, 2H), 2.72 (d, 6H, 1=4.8 Hz), 2.52 (d, 
3H, 1=4.2 Hz), 2.24 (m, 6H), 2.02 (m, 2H), 1.76 (m, 4H); MS (MALDI-TOF): [M+Ht 
1279.7. (C62H79N20011+' [M+Ht, calc. 1279.6). 
ImPyPyPy(DpC30Me)-'Y-PyPyPyPy-~-Me (6). MsCI activation of crude 
ImPyPyPy(C30H)-y-PyPyPyPy-~-Me (24 Ilmol) as for 4 followed by redissolving of the 
precipitate in DMF (3 mL), reaction with 3-methoxypropylamine (1 mL, 90° C, 30 min.) 
and preparatory reverse phase HPLC afforded ImPyPyPy(DpC30Me)-y-PyPyPyPy-~-Me 
(6) upon lyophilization of the appropriate fractions (1.5 mg, 1.2 Ilmol, 5.0% recovery); 
UV (H20) "'max 312 (66,000); IH NMR (DMSO-d6 ): 8 10.44 (s, IH), 9.96 (s, IH), 9.95 (s, 
IH), 9.91 (s, IH), 9.88 (s, IH), 9.88 (s, IH), 9.83 (s, IH), 8.24 (m, 2H), 8.20 (m, IH), 
7.99 (m, IH), 7.80 (m, IH), 7.37 (d, IH, 1=0.6 Hz), 7.32 (d, IH, 1=1.8 Hz), 7.26 (d, IH, 
1=1.8 Hz), 7.20 (m, 3H), 7.16 (m, 3H), 7.06 (d, IH, 1=1.8 Hz), 7.01 (m, 3H), 6.89 (d, IH, 
1=1.5 Hz), 6.84 (d, IH, 1=1.8 Hz), 6.79 (d, IH, 1=2.1 Hz), 4.30 (m, 2H), 3.96 (s, 3H), 
3.82 (s, 9H), 3.81 (s, 3H), 3.81 (s, 3H), 3.76 (s, 3H), 3.19 (s, 3H), 2.90 (m, 4H), 2.52 (m, 
5H), 2.42 (m, 2H), 2.27 (m, 6H), 2.00 (m, 2H), 1.78 (m, 4H); MS (MALDI-TOF): 
[M+Ht 1265.8, [M+Nat 1287.8, [M+Kt 1303.8. (C61H76N20011+' [M+Ht, calc. 1265.6; 
C61H76N20NaOll+' [M+Nat, calc. 1287.6; C61H76KN20011+' [M+Kt, calc. 1303.6). 
ImPyPyPy(DpDp)-'Y-PyPyPyPy-~-Me (7). MsCl activation of crude ImPyPyPy(C30H)-
y-PyPyPyPy-~-Me (23 Ilmol) as for 4 followed by redissolving of the precipitate in 
pyridine (0.75 mL), reaction with N,N,N'-trimethyl-l,3-propanediamine (0.75 mL, 90°C, 
40 min.) and preparatory reverse phase HPLC afforded ImPyPyPy(DpDp)-y-PyPyPyPy-
~-Me (7) upon lyophilization of the appropriate fractions (6.7 mg, 5.2 Ilmo1, 23% 
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recovery); UV (H20) Amax 312 (66,000); 'H NMR (DMSO-d6 ): 8 10.45 (s, IH), 9.97 (s, 
IH), 9.95 (s, IH), 9.92 (s, IH), 9.89 (s, IH), 9.88 (s, IH), 9.84 (s, IH), 9.55 (m, IH), 8.44 
(m, IH), 8.19 (m, IH), 7.98 (m, IH), 7.80 (m, IH), 7.37 (m, IH), 7.34 (d, IH, 1=1.8 Hz), 
7.26 (d, IH, 1=1.8 Hz), 7.20 (s, 3H), 7.15 (m, 2H), 7.07 (d, IH, 1=1.5 Hz), 7.01 (m, 3H), 
6.88 (d, IH, 1=1.8 Hz), 6.84 (d, IH, 1=1.8 Hz), 6.79 (d, IH, 1=1.8 Hz), 4.30 (m, 2H), 3.96 
(s, 3H), 3.82 (s, 9H), 3.81 (s, 6H), 3.80 (s, 3H), 3.35 (m, 4H), 3.20 (m, 2H), 3.00 (m, 2H), 
2.75 (m, 9H), 2.54 (d, 3H, 1=4.5 Hz), 2.26 (m, 6H), 2.04 (m, 2H), 1.96 (m, 2H), 1.77 (m, 
2H); MS (MALDI-TOF): [M+Ht 1292.7 (C63H82N2'OIO+' [M+H]+' calc. 1292.7). 
ImpyPyPy(DpDp)-y-ImPyPyPy-Ji-Me (8). Crude ImPyPyPy(C30H)-y-ImPyPyPy-I3-Me 
(23 Jlmol) was dissolved in pyridine (150 JlL) and activated with TsCI (4.8M in pyridine, 
200 JlL) for 1 hour at 0 °C. The addition of N,N,N'-trimethyl-l,3-propanediamine (0.30 
mL, 55°C, 30 min.) followed by preparatory reverse phase HPLC afforded 
ImPyPyPy(DpDp)-y-ImPyPyPy-I3-Me (8) upon lyophilization of the appropriate fractions 
(0.4 mg, 0.3 Jlmol, 1.3% recovery); UV (H20) "'max 312 (66,000); 'H NMR (DMSO-d6 ): 8 
10.43 (s, IH), 10.26 (s, IH), 9.96 (s, IH), 9.93 (s, IH), 9.91 (s, 2H), 9.86 (s, IH), 9.45 
(m, IH), 8.17 (m, IH), 7.97 (m, IH), 7.78 (m, IH), 7.41 (s, IH), 7.36 (s, 2H), 7.33 (s, 
IH,), 7.25 (s, IH), 7.22 (s, IH), 7.18 (s, 2H), 7.14 (s, IH), 7.14 (s, IH), 7.11 (s, IH), 7.00 
(s, 2H), 6.86 (s, IH), 6.77 (s, IH), 4.24 (m, 2H), 3.96 (s, 3H), 3.91 (s, 3H), 3.80 (s, 12H), 
3.75 (s, 3H), 3.35 (m, 4H), 3.20 (m, 2H), 3.00 (m, 2H), 2.74 (d, 9H, 1=3.6 Hz), 2.52 (d, 
3H, 1=4.8 Hz), 2.27 (m, 6H), 2.05 (m, 2H), 1.94 (m, 2H), 1.78 (m, 2H); MS (MALDI-
TOF): [M+Hr 1293.9 (C62Hs,N2201O+' [M+Ht, calc. 1293.7). 
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CHAPTERS 




Cell permeable synthetic ligands that bind to predetermined DNA sequences will 
offer a chemical approach to gene regulation if inhibition of a broad range of 
transcription factors can be achieved. Pyrrole/imidazole hairpin polyamides inhibit DNA 
binding by NF-KB at nanomolar concentrations. Inhibition was observed only for the 
ligands that bind the 5' -GGGAC-3' subsite and not the 5' -TTCC-3' subsite of the 
heterodimeric protein binding site. Polyamides that bind the NF-KB site incorporate new 
motifs for high binding of G,C rich sequences that have not been achieved using 
previously reported molecules. Addition of NF-KB to the list of protein-DNA complexes 
that can be disrupted by minor groove binding ligands potentially increases the utility of 
polyamides as regulators of gene expression. 
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Introduction 
Hairpin polyamides containing pyrrole (Py), imidazole (1m) and hydroxypyrrole 
(Hp) amino acids are synthetic ligands that bind predetermined DNA sequences in the 
minor groove with affinities and specificities comparable to many DNA binding proteins 
(1, 2 ). Rules have been developed that allow for sequence specific recognition of the 
DNA minor groove by relating each Watson Crick base pair with a particular pairing of 
the aromatic Py, 1m and Hp rings (J -4). The crescent shaped polyamides bind in the 
minor groove of DNA with pairs of aromatic rings stacked against each other and the 
walls of the groove, allowing the backbone amide hydrogens and the substituents at the 
3-position of the Py, 1m and Hp residues to make specific contacts with the edges of the 
intact base pairs. An y-aminobutyric acid residue (y) connects the polyamide subunits in a 
"hairpin" motif that enhances affinity and unambiguously locks the desired ring pairings 
in register (1, 2). 
In order for minor groove binding polyamides to be utilized as regulators of gene 
transcription, strategies must be developed that permit inhibition of all classes of DNA 
binding proteins, particularly transcription factors which bind regulatory elements in gene 
promoter regions. Working toward this goal, polyamides have been found to interfere 
with DNA binding for several classes of proteins (5). An examination of the available 
crystal structures of these proteins reveals that inhibition usually occurs when a hairpin 
polyamide targets a key protein-DNA contact in the minor groove. In an initial study a 
polyamide inhibited TFIIIA binding when it was bound to the position where one of 
TFIIIA's zinc fingers crosses the minor groove (6, 7). In other cases polyamides inhibited 
targeted TATA Box-binding protein, TBP, and LEF-l, when bound immediately adjacent 
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to their binding sites. Both of these proteins bind DNA in the minor groove and bend and 
unwind the DNA helix (8). It is believed that polyamides lock the DNA into a B-type 
formation and serve as a steric blockage, preventing protein binding. In the case of 
winged-helix-turn-helix transcription factor ETS-l, binding by the protein was inhibited 
when a polyamide was targeted to a loop that binds across the minor groove (8, 9). In 
contrast, polyamides have been shown to bind simultaneously with some proteins such as 
bZIP protein, GCN4, that exclusively occupy the DNA major groove, unless key 
phosphate contacts are targeted with a ligand with multiple positive charges displayed on 
a polyamide (10, II). In this case we learned that it was necessary to target a specific 
phosphate for optimal inhibition. The DNA binding of other proteins has also been 
successfully inhibited, but many other protein classes have yet to be targeted by 
polyamides (see Table 5.1). Each new class of proteins presents a different challenge for 
designing minor-groove binding polyamides that can inhibit protein-DNA binding, 
especially for proteins that predominantly dock to the major groove of DNA. 
Table 5.1. Protein Targets for Polyamide Inhibitors 
Protein DNA-Binding Motif 
TFIIIA zinc finger 
TBP minor groove/saddle 
LEF-I HMGBox 
Ets-l winged-helix-turn-helix 
IE-86 minor groove 
Estrogen Receptor C4 zinc finger 
Deadpan basic helix-loop-helix 
GCN4 bZip 
Tax minor groove 
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NF-1d3 p50/p65 is a heterodimeric protein that was first characterized as a nuclear 
factor that binds to the K light-chain enhancer in B-Iymphocytes (12). Subsequently, NF-
KB has been found to activate transcription as part of signal transduction pathways in 
many different cell types and regulates genes involved in immune and inflammatory cell 
function (13, 14) and in anti-apoptotic responses (15-18). While p50 and p65 can bind as 
both homo- and heterodimers, the p50/p65 heterodimer is most prevalent (19). The DNA-
binding domains of both p50 and p65 are located near their N-termini and are members 
of the Rei homology domain family of DNA-binding domains, consisting of two 
immunoglobulin-like B-sandwich domains joined by a linker region with the C-terminal 
domain mediating dimerization contacts (20, 21). DNA contacts are formed with loops 
joining B-strands in both the N- and C-terminal domains. The heterodimer binds 5'-
GGGACTTCC-3' . The p65 monomer derives its specificity from contacts in the major 
groove for the four-base pair subsite (5'-TTCC-3'), while the p50 monomer recognizes a 
five base-pair subsite (5' -GGGAC-3 '). The heterodimer makes several phosphate 
p65_Lys~21 p65-Lys~ 23 pSO_,Lys145 
, , ' 
5' -T . G.G.G. G'.A. C . T~T.T;C.C - 3 ' 
p65-Lysl22 
3 '-C · C·C,.C.T.G,~A~A.A·G·G.A-5' 
P65-L;;;~ PSO-L;;;;S ~'~_LYSl44 
Figure 5.1. (left) Crystal Structure of p50p65 NF-KB heterodimer:DNA complex. The p50 and p65 
monomers are colored blue and read respectively. Amino acid side chains that contact DNA are colored 
white. (right) NF-KB contacts to the minor groove and phosphate backbone contacts. 
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contacts and the minor groove is accessible with the exception of p50-Lys145, which 
contacts phosphates on either side of the minor groove of DNA (21) (see Figure 5.1). 
We report here the synthesis and DNA binding properties of a series of hairpin 
polyamides targeted to the NF-KB binding site and their ability to inhibit NF-KB. 
Polyamides were designed to bind overlapping sites along the protein-binding site to 
determine which sites provided optimal inhibition. The DNA binding affinity and 
specificity of each of these compounds for their target DNA site was evaluated using 
quantitative DNase I footprinting. Gel mobility shift assays were employed to investigate 
the ability of these polyamides to inhibit the interaction of NF-KB with DNA. 
NF-KB 
I I 
5'-G A G G G G ACT T T C C GAG A-3' 
3'-C T C C C C T G A A A G G 
~ 1 
HO~ 2 




C T C T-5' 
Figure 5.2. A ball and stick representation of polyamides bound to an NF-KB DNA binding site. Filled 
circles represent imidazole rings while open circle denote pyrrole rings. The diamond represents p-alanine, 
OH represents a propanol amide and R-diaminobutyric acid is depicted as a curved line and a plus sign. 
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Results and Discussion 
Polyamide Design and Synthesis. Polyamides 1-8 that cover the NF-1(B binding site 
were synthesized using solid-phase methods as previously described (22-24). Polyamides 
1 and 5-7 were synthesized on oxime resin and cleaved with methyl amine to yield 
methyl amide tails, which allow the binding of sequences with G,C base pairs flanking 
the paired rings (24). Polyamides 2-4 and 8 were synthesized on Boc-p-alanine-PAM-
resin followed by reductive cleavage to yield a p-propanol tail (22). Ring-p pairings were 
incorporated into these polyamides, since linkage 5 of contiguous rings results in 
decreased binding (25). Unpaired pyrrole rings were placed over two G,C base pairs 
because previous attempts to bind four consecutive G's with rings pairs results in low 
affinity compounds (26). Presumably the pyrrole ring should be positioned to avoid the 
exocyclic amine of guanine, since it is pushed up against the other side of the groove. 
Compound 8 incorporates a l-(N -Boc-3-aminopropy 1)-2- imidazole carboxy late 
monomer, allowing the charge to be located on the terminal imidazole. The monomer 
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Figure 5.4, Structures of polyamides 1-8 targeted to the NF-KB binding site, 
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Quantitative DNase I footprint titrations. Polyamide 1 binds its target site with 
relatively high affinity, but as with the parent compounds, coating is observed soon after 
occupation of the target site (30 nM). As a result the compound's lack of specificity will 
limit its utility. Series 2-4 reveals decreasing affinity for the target site. The pairing of p 
with the N-terminal imidazole monomer appears to be less optimal than an internal ring-
p pair since polyamide 3 has a binding affinity fivefold lower than that of compound 2. 
Compound 4 that has only two ring pairings and therefore shows lower affinity than 
either 2 or 3 and displays little specificity for the target sites, since many match sites exist 
on the labeled fragment. Evidently the unpaired pyrrole ring in each of these compounds 
is well tolerated by the G,C base pair. Presumably A,T base pairs would also be tolerated 
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by the ring. The unpaired pyrrole ring does allow for binding of the four consecutive G's 
with high affinity, which has not been accomplished previously. This motif will allow 
exploitation of the binding site immediately adjacent to the four G's for specificity, while 
still binding the G-rich site. Larger compounds were synthesized based on this motif in 
order to increase the specificity of the compounds by binding a larger binding site. Two 
imidazoles were incrementally added to the N-terminus of compound 2 to provide ring 
pairing across the G,C base pairs. Both compounds did not show binding of their target 
site and began to nonspecifically bind DNA at 30 nM. The eight-ring hairpin analogue of 
2, compound 5 binds with comparable affinity and specificity. Relocation of the charge 
from the turn to the terminal imidazole in compound 8 also did not affect binding affinity 
or specificity. The failure of the larger poly ami des to bind DNA suggests that the 
structure of the DNA is irregular. Compounds 6 and 7 show good affinity and specificity 
for their target sites comparable to other hairpin polyamides that have been reported. 
Table 5.2. Equilibrium Association Constants (M- I )" 
Polyamide 
Imlmlmlm- H2Ny_PyPyPyPy_NHCOMe (1) 
ImlmPyPy-H2Ny-ImPy-j3-PyPyPy-NHCOPrOH (2) 
ImlmPyPy-H2Ny-ImPyPy-j3-PyPy-NHCOPrOH (3) 
ImPYPy_ H2Ny-ImPy-j3-PyPyPy-NHCOPrOH (4) 
ImlmPyPy- H2Ny-ImPyPyPy-NHCOMe (5) 
ImPyPyPylm- H2Ny-PyPyPyPyPy-NHCOMe (6) 
ImlmPyPy- H2 NY_PyPyPyPy_NHCOMe (7) 
Im(C}NH2)lmPyPy-H2Ny-ImPy-j3-PyPyPy-NHCOPrOH (8) 
K, 
8.0 X 109 
9.3 (±1.6) x 109 
1.4 (±O.l) x 109 
2.2 (±0.6) x IO~ 
2.2 (±0.3) x 1010 
6.4 (±1.6) x 109 
1.3 (±0.2) x 109 
"Values reported are the mean values obtained from three DNase I footprint 
titration experiments except compounds, 1 and 8, which are averages of two gels. 
The assays were carried out at 22°C, 10 mM Tris·HCI (pH 7.0), 10 mM KCI, 10 
mM MgCI2, and 5 mM CaCI2• The match sites are 5'-agAGGGGac-3' for 1, 5'-
gaGGGGACTtt-3' for 2-4 and 8, ggGGACTtt-3' for 5, 5'-ggACTTTCcg-3' for 6 
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Figure 5.5. Storage phosphor auto radiograms of quantitative DNase I footprint titration experiments with Imlmlmlm-
H2Ny_PyPyPyPy_NHCOMe (1), ImlmPyPy-H2Ny-ImPy-~-PyPyPy-NHCOPROH (2), ImlmPyPyJI2Ny-ImPyPy-~-PyPy­
NHCOPROH (3), ImPyPy-H2Ny-ImPy-~-PyPyPy-NHCOPROH (4), ImlmPyPy-H2Ny-ImPyPyPy-NHCOMe (5), 
ImPyPyPylm-H2Ny-PyPyPyPyPy-NHCOMe (6), ImlmPyPy-H2Ny-PyPyPyPy-NHCOMe (7), Im(C,NH2)ImPyPy-H2Ny-
ImPy-~-PyPyPy-NHCOPROH (8) on the 3'-,2P-end-Iabeled restriction fragment. All reactions contained 10 kcpm 
restriction fragment, \0 mM TrisoHCi (pH 7.0), 10 mM KCI, \0 mM MgCI2 and 5 mM CaCI2 and were performed at 22 
0c. For compounds 1, 6 or 7 Lane I, intact DNA; lane 2, A-specific reaction; lane 3, G-specific reaction; lane 4, 
DNase I standard; lanes 5-15, \0 pM, 30 pM, \00 pM, 300 pM, I nM, 30 nM, 100 nM, 300 nM, 111M. For compounds 
2,4 or 5 Lane I, intact DNA; lane 2, A-specific reaction; lane 3, G-specific reaction; lane 4, DNase I standard; lanes S-
IS, I pM, 30 pM, 10 pM, 30 pM, \00 pM, 300 pM, I nM, 30 nM, \00 nM. Each gel contains two match binding sites 
that are bracketed. Match binding sites are to the right of each gel in capital letters. 
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Figure 5.6. NF-rl3 gel mobility shift assay with polyamides 1-7. 
NF -KB Binding Inhibition by Polyamides determined by Gel Shift. 
Gel mobility shift assays were performed with P-32 labeled double-stranded 
oligonucleotides and nuclear extract isolated from TNFu activated 293T cells (17). 
Compounds 2, 3 and 5 that bind the GGGAC subsite of the NF-K8 binding site inhibited 
the protein's binding to DNA at nanomolar concentrations. Higher concentrations were 
necessary for inhibition by 3, a low affinity binder than compounds 2 or 5, indicating that 
inhibition is dependent on the binding constant. Polyamides 6 and 7 bound the TTCC 
sub site of the NF-KB binding site did not inhibit at concentrations up to 111M. Inhibition 
at low nanomolar concentrations compare favorably to other protein binding inhibition 
results with polyamides. 
Analysis of the NF-KB DNA crystal structure reveals two possible mechanisms 
for inhibition of the complex formation by polyamides: allosteric and steric. The minor 
groove of the DNA bound by NF-KB has a narrow minor groove of approximately 4 
angstroms (21). Polyamides are known to slightly enlarge the minor groove when bound 
there to approximately 7.5 angstroms (27) (Figure 5.7A). The p50 half of the heterodimer 
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makes extensive major groove contacts on the 5'-GGGAC-3' subsite of the binding site, 
but few minor groove interactions in this region. Potentially the polyamide binds to the 
DNA sequence, enlarging the minor groove, stabilizing a conformation that cannot be 
bound by this half of the NF-KB dimer. Alternatively, the p65-Lys221 in the minor 
groove in this region could be blocked by these polyamides (Figure 5.7B) . Likely a 
combination of these interactions contributes to the inhibition of the p50p65 heterodimer. 
A 
B 
Figure 5.7. (A) Left, a structure of DNA when bound by a polyamide with a wide minor groove. Right, the 




Once it was established that polyamides could inhibit DNA binding by NF-KB, 
we set out to determine whether the compounds could inhibit expression of a gene that 
used NF-KB as a transcription factor. A plasmid with an NF-KB responsive promoter 
attached to a luciferase reporter was transfected into 293T cells (28). Polyamides were 
added to the cell media to give a final concentration of 100 nM and 1 JlM and incubated 
overnight. TNFa was added to the cells to activate transcription. Little, if any, decreased 
transcription was observed for compounds 1-8 tested (any decrease observed was within 



















Figure 5.8. Additional polyamides synthesized to inhibit NF-KB. Polyamides are represented as in Figure 
2, expect an H depicts a hydroxypyrrole ring. Red colored base pairs show site where the binding site was 
altered. 
In parallel with this study, researchers in the Dervan group were studying cell 
permeability by polyamide-dye conjugates. Preliminary results indicated that the 2-(3-2 
polyamide motif was less cell permeable than a fully paired eight-ring hairpin polyamide. 
In light of this data, additional compounds 13-22 were synthesized that target the region 
that was known to inhibit NF-KB-DNA complex formation (Figure 5.8). A variety of 
motifs were used in an effort to see if these compounds would have increased cellular 
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uptake. The reporter plasmid was mutated to allow binding of the different motifs. These 
compounds incorporated fully ring paired analogues, ~-ring pairings, ~-Dp tails, 
extended hairpins and Hp/Py pairings. Although these compounds except 16 inhibited 
NF-KB DNA-binding, they were unsuccessful at downregulating the NF-KB driven 
reporter in cell culture. 
Conclusions 
A series of polyamides were synthesized that target overlapping regions in a NF-
KB binding site. These compounds include a new motif that incorporates unpaired pyrrole 
rings over a C,G base pair that allow binding of four consecutive guanines with 
subnanomolar affinity as well as the first application of polyamides with methyl amide 
tails. This successful targeting of the 5' -CCTT -3' subsite with the polyamides with 
methyl amine tails demonstrates the utility of the new tail for recognition of G,C rich 
sequence that would be difficult using previous methods. Polyamides targeted to the left 
side of the protein binding site inhibited the NF-KB-DNA complex at low nanomolar 
concentrations. The successful inhibition of NF-KB suggests that polyamides could likely 
be used to inhibit other proteins that are members of the ReI homology family of DNA-
binding proteins. Once cell trafficking of polyamides is figured out, then we hope to use 
these compounds to investigate their effects on gene regulation. One can envision 




1-(N-Boc-3-aminopropyl)imidazole. Boc anhydride (17.5 g, 80 mmol) was added to a 
solution of 1-(3-aminopropyl) imidazole in ethyl acetate (120 ml) and 20% aqueous 
potassium carbonate (100 ml). After stirring for 8 h at room temperature, the organic 
layer was separate, washed with sat'd sodium bicarbonate (1 x 50 ml), brine (1 x 50 ml), 
and concentration in vacuo to yield a colorless oil (15.1 g, 83.3% yield). 'H NMR 
(DMSO-d6 ): 07.61 (s, 1H), 7.12 (s, 1H), 6.92 (bt, 1H), 6.83 (s, 1H), 3.91 (t, 2H, J= Hz), 
2.86 (d of d, 2H, J= Hz), 1.78 (m, 2H), 1.35 (s, 9H). 
1-(N-Boc-3-aminopropyl)-2-imidazole carboxylate. A solution of 1-(N-Boc-3-
aminopropyl)imidazole (13.8 g, 61.3 mmol) in dry THF (150 ml) under argon was cooled 
to -72°C. nButLi (61 ml, 2.0 M in hexanes) was added to the reaction mixture. After 
stirring for 1.5 h, CO2 (g) was bubbled through the reaction mixture for 2 h. The reaction 
was acidified with HCI (aq, 1 N, -61 ml) to pH 8. The aqueous layer was frozen and 
lyophilized to yield a white solid (11.4 g). The crude solid was purified on reverse phase 
Cl8 silica gel with 0.1 % TFA (aq) and acetonitrile to yield a white solid (5.7 g, 34.6% 
yield). 'H NMR (DMSO-d6 ): 0 7.16 (s, IH), 7.01 (bt, IH, J= Hz), 6.82 (s, 1H), 4.45 (t, 
2H, J= Hz), 2.82 (d of d, 2H, J= Hz), 1.75 m (2H), 1.37 (s, 9H). 
Polyamide Synthesis. As previously reported (2,22,24). 
Quantitative DNase I Footprinting. As previously reported (29). 
Gel Mobility Assays. As previously reported (17). 
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CHAPTER 6 
Sequence Specific Alkylation of DNA by Hairpin Pyrrole-
Imidazole Polyamide Conjugates 
The text o/this chapter was taken in part/rom a publication coauthored with Prof Peter 
Dervan. 
(N.R. Wurtz & P.B. Dervan Chern. & Bioi., 2000,7,152-161.) 
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Abstract 
Pyrrole/imidazole polyamides are synthetic ligands that recognize predetermined 
sequences in the minor groove of DNA with affinities and specificities comparable to 
DNA-binding proteins. As a result of their DNA binding properties, polyamides could 
deliver reactive moieties for covalent reaction at specific DNA sequences and thereby 
inhibit DNA-protein interactions. Site-specific alkylation of DNA could be a useful tool 
for regulation of gene expression. As a minimal first step, we set out to design and 
synthesize a class of hairpin polyamides equipped with DNA alkylating agents and 
characterize the specificity and yield of covalent modification. Bis(dichloroethylamino)-
benzene derivatives of the well-characterized chlorambucil (CHL) were attached to the y-
tum of an eight-ring hairpin polyamide targeted to the HIV promoter. We found that a 
hairpin polyamide-CHL conjugate binds and selectively alkylates predetermined sites in 
the HIV promoter at subnanomolar concentrations. Cleavage sites were determined on 
both strands of a restriction fragment containing the HIV -1 promoter revealing good 
specificity and high yield of alkylation. The ability of polyamide-CHL conjugates to 
sequence specifically alkylate double stranded DNA in high yield and at low 
concentration sets the stage for testing their use as regulators of gene expression in cell 
culture and ultimately in complex organisms. 
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Introduction 
Small molecules specifically targeted to any predetermined DNA sequence would 
be useful tools in molecular biology and potentially in human medicine. Polyamides 
containing pyrrole (Py), and imidazole (1m) amino acids, are synthetic ligands that have 
an affinity and specificity for DNA comparable to naturally occurring DNA binding 
proteins (1-5). DNA recognition depends on side-by-side amino acid pairings in the 
minor groove. An antiparallel pairing of 1m opposite Py (lrnJPy) distinguishes G-e from 
e-G and both of these from A-Trr-A base pairs (6-9). A Hp/Py pair specifies T-A from 
A-T and both of these from e-G/G-e (10, 11). The linker amino acid, y-aminobutyric 
acid (y), connects polyamide subunits e~N in a "hairpin motif," and these ligands bind 
to predetermined target sites with> 100 fold enhanced affinity relative to unlinked dimers 
(1-4, 12). Paired \3-alanine residues (\3/\3) restore the curvature of the dimer for 
recognition of larger binding sites and, in addition, code for AT/TA base pairs (13-15). 
Eight-ring hairpin polyamides permeate eukaryotic cells and have been shown to regulate 
transcription by targeting promoters of specific genes (16, 17). 
Sequence specific covalent attachment in the DNA minor groove by small molecules 
In unpublished observations, hairpin polyamides do not appear to inhibit gene 
expression when bound to the coding region of genes. In order to inhibit elongation by 
the RNA polymerase enzymes, it may be that one needs either higher affinity class of 
DNA binders or alternatively bifunctional molecules that covalently attach to 
predetermined sequences in the minor groove of DNA. In this paper we address this 
latter class of molecules, the design of hairpin polyamides with separate domains for 
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DNA binding and DNA covalent attachment. This is a minimal first step toward creating 
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Figure 6.1. Top, the hydrogen-bonding model and alkylation mechanism of polyamide-chlorambucil 
conjugate ImPy-~-ImPy-(R)cHLy-ImPy-~-ImPy-~-Dp (2) bound to the minor groove of 5' -AGCTGCT-3'. 
Circles with two dots represent the lone pairs of N3 purines and 02 of pyrimidines. Circles containing an 
H represent the N2 hydrogens of guanines. Putative hydrogen bonds are illustrated by dotted lines. Bottom, 
model of polyamide conjugate 2 bound to the match site 5'-AGCTGCT-3'. Black and white circles 
represent imidazole (1m) and pyrrole (Py) polyamide rings, respectively. Diamonds and hexagons 
represent ~-alanine (~) and chlorambucil (CHL) respectively. (R)-2.4-diaminobutyric acid «Ry) and 
dimethylamino-propylamide (Dp) are depicted as a curved line and a plus sign, respectively. 
Hairpin polyamide-bis( dichloroethylamino )benzene conjugates 
Nitrogen mustards are well characterized DNA alkylators with little sequence 
specificity (18). A freely diffusing bis(dichloroethylamino)benzene moiety such as 
chlorambucil reacts with the more nucleophilic N7 of guanine in the major groove, but 
will alkyl ate the N3 of adenine in the minor groove when attached to minor groove DNA 
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binding ligands (19, 20). The combination of subnanomolar binding hairpin polyamides 
and bis(dichloroethylamino)benzene derivatives creates a class of bifunctional agents that 
bind to predetermined DNA sequences with high affinity and specificity for subsequent 
covalent reactions at N3 of adenine. Key design issues are sites of attachment of the 
functional domains and the choice of linker length and flexibility. In order to target the 
adenines adjacent to polyamide binding sites, we chose to attach 
bis(dichloroethylamino)benzene derivatives to the chiral a-amino group on the y-tum of 
a pyrrole/imidazole hairpin polyamide. 
(1) ImPy-f3-ImPy-y-ImPy-f3-ImPy-f3-Dp (2) ImPy-f3-ImPy-(R)CHLy-ImPy-f3-ImPy-f3-Dp 
(3) ImPy-f3-ImPy-(R)BAMy-ImPy-f3-ImPy-f3-Dp (4) ImPy-f3-ImPy-(RfHL(OH)2.y-ImPy-f3-ImPy-f3-Dp 
CI 
~ 




N -[3-( dimethylamino )propyl]butanamide 
Figure 6.2. Structures of poly ami des 1-4 and a nonspecific alkylator 5_ 
Polyamide 1 has been shown to bind the sequence 5'-WGCWGCW-3' adjacent to 
both sides of the TATA box in the HIV promoter with high affinity (Ka = 2.0 X lO tO M- 1) 
(16). Substitutions at the a position of the y -tum using (R)-2,4-diaminobutyric acid 
potentially have only a modest effect on DNA binding affinity or specificity (21). We 
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chose this as the point of attachment of a nondiffusible electrophile that would react at 
the N3 of adenine adjacent to the polyamide-binding site. Chlorambucil (CHL), 4-[bis(2-
chloroethyl)amino]benzene butanoic acid, which has a simple flexible linker and the less 
reactive 4-[bis(2-chloroethyl)amino]benzenoic acid were chosen as alkylators. Since 
alkylation by the electrophile results in irreversible binding, a non-alkylating conjugate 4 
in which the chlorides have been replaced with hydroxyls was also synthesized as a 
control to investigate energetic penalty (or lack thereof) on polyamide binding affinity 
and specifici ty for the target sequence. In addition compound 5 will serve as a control to 
compare alkylation of the alkylating moiety unlinked to a polyamide. 
pHIV-LTR 
Hind III Eco RI 241 bp 




Figure 6.3. An illustration of the 241 bp pHIV -LTR EcoRIIHindIlI restriction fragment with the position 
of the sequences indicated. The binding sites 5'-AGCTGCT-3', 5'-TGCAGCA-3' and 5'-TGCAGCT-3' 
are highlighted in gray. 
Here, we report preliminary results on our first generation of hairpin polyamides 
that selectively alkylate and cleave DNA in the minor groove. Alkylation adducts and 
cleavage yields were determined using thermal cleavage assays on a 241 base pair 
restriction fragment and 120 base pair synthetic oligonucleotides. DNA binding affinity 








Figure 6.4. Synthetic scheme for preparation of polyamide conjugate, ImPy-I3-ImPy-(R)cHLy-
ImPy-I3-ImPy-I3-Dp (2). The HOBt-activated nitrogen mustard 7 is coupled with standard 
DCC/HOBt activation to polyamide 6 and purified by reverse phase HPLC (step i). The 
hydrolyzed conjugate 4 is prepared by addition of 0.1 M NaOH (step ii). 
Results and Discussion 
Synthesis of Conjugates 
Polyamide 6, ImPy-I3-ImPy-(R)H,Ny-ImPy-I3-ImPy-I3-Dp, was prepared by manual 
solid phase polyamide synthesis (22). After purification by reverse phase high 
performance liquid chromatography (HPLC), the appropriate activated carboxylate 
derivative of bis(dichloroethylamino)benzene was coupled to the a-amino group on the 
y-turn, using standard DCC/ HOBt conditions, to yield polyamide-nitrogen mustard 
III 
conjugates 2 and 3 (Figure 4). Control conjugate 4 was synthesized by allowing 2 to 
react with 0.1 M NaOH, followed by neutralization and lyophilization. Control 
compound 5 was synthesized by coupling chlorambucil to (dimethylamino)-propylamine 
(Dp). All compounds were purified by reverse phase HPLC. MALDI-TOF mass 
spectrometry analysis of each compound was consistent with the calculated mass of the 
compounds. 
Polyamide binding affinity and specificity is unaltered by substitution 
Quantitative DNase I footprint titration experiments were performed on 
compound 4 to measure the equilibrium association constant for the match binding sites 
(5'-WGCWGCW-3') on a 241 bp restriction fragment derived from the HIV-1 promoter 
region (Figure 6.5). The conjugate binds the match sites 5'-AGCTGCT -3' and 5'-
TGCAGCA-3' with equilibrium association constants of Ka = l.6 ± 0.7 x lO lD M-' and l.3 
± 0.7 x 1010 M-', respectively. This is remarkably similar to unsubstituted polyamide 1 
(Ka = 2.0 x 1010 M-')(J7). Affinities for the double base pair mismatch sites, 5'-
TGTCGCC-3' and 5'-AGCAGCTC-3', were determined to be >100 fold lower than for 
the match sites. Attachment of the benzene moiety to the y turn does not appear to affect 
the DNA binding affinity or specificity of the polyamide. 
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Figure 6.5 (a) Quantitative DNase I footprint titration experiments with ImPy_~_ImPy_(R)cHL(OH)2y_ImPy_~_ 
ImPy-~-Dp (4) on the 3'-32P-end-Iabeled 241 base pair EcoRIIHindIIl restriction fragment from plasmid 
pHIV-LTR(23). Left, storage phosphor autodiograms of 8% denaturing polyacrylamide gels used to 
separate the fragments generated by DNase I digestion. All reactions contained 20,000 cpm restriction 
fragment, 10 mM Tris·HCI (pH 7.0), 10 mM KCI, 10 mM MgCI2 and 5 mM CaCI2 and were performed at 
22°C. Lane I, intact DNA; lane 2, A-specific reaction; lane 3, G-specific reaction; lane 4, DNase I 
standard; lanes 5-17,1 pM, 2 pM, 5 pM, 10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 1 nM, 2 nM, 5 
nM, 10 nM, respectively. The 5'-AGCTGCT-3' (A), 5'-TGCAGCA-3' (B), and 5'-TGCTGCT-3' (E) 
match sites are shown in boxes on the right side of the autoradiogram. (b) Data from quantitative DNase I 
footprint titration experiments for ImPy_~_ImPy_(R)cHL(OH)2y_ImPy_~_ImPy_~_Dp (3) binding to the 5'-
AGCTGCT-3' (A) and 5'-TGCAGCA-3' sites (B). 8norm points were obtained using storage phosphor 
autoradiography and processed as described in the experimental section. The solid curves are best-fit 
Langmuir binding titration isotherms obtained from a nonlinear least-squares algorithm eq 2 (n=l). 
DNA alkylation by polyamide conjugate proceeds in high yield 
In order to measure DNA cleavage, thermal cleavage assays were performed on 
3' and 5' 32p labeled 241 base pair restriction fragments containing the HIV -1 promoter 
(Figure 6.6) (24). Alkylation in high yield was observed at subnanomolar concentrations 
for conjugate 2. In fact quantitative cleavage by conjugate 2 at 10 nM concentration was 
observed on one strand (bottom strand, Figure 6.2). In contrast, no cleavage was observed 
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at 10 11M with compound 3 or at 10 mM concentration of the freely diffusing 







8 « 0 n 

































c: o u « 0 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ..... -------_. -
... ... ..-. ... - ....... "' 
- - .... till .- - - - - .... 
\ "p"P J 
Figure 6.6. Thermal cleavage assay experiments with ImPy-i3-ImPy-(R)CHLy-ImPY-i3-ImPy-i3-Dp (2) 
on the 5'and 3'-32P-end-Iabeled 241 base pair EcoRI/HindIII restriction fragment from plasmid 
pHIV-LTR(23). Storage phosphor autodiograms of 8% denaturing polyacrylamide gels used to 
separate the fragments generated by heat induced DNA cleavage at alkylation sites. All reactions 
contained 10,000 cpm restriction fragment, 10 mM TriseHCl (pH 7.0),10 mM KCl, 10 mM MgCl2 
and 5 mM CaCl2 and were performed at 37° C. Following 24 hour of equilibration, the DNA 
pellet was resuspended in sodium citrate buffer (pH=7.2) and heated to 90° C for 15 min to 
thermally cleave at sites of adenine- or guanine-N3 lesions. (a) 5'-32P-end-Iabeled restriction 
fragment. (b) 3'-32P-end-Iabeled restriction fragment. (a-b) Lane 1, intact DNA; lane 2, A-specific 
reaction; lane 3, G-specific reaction; lanes 5-13, 10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 1 
nM, 2 nM, 5 nM, 10 nM, respectively. (b) Lane 14,10 11M CHL-Dp (5). Center, alkylation sites on 
the DNA fragment, indicated by arrows. Sites 5'-TCGTCGACGA-3' (A), 5'-ACGTCGA-3' (B), and 
5'-ACGTCGA-3' (E) are match sites and 5'-ACATCTT-3' (C) and 5'-TCGTCAG-3' (D) are double 
base pair mismatches (mismatches indicated by gray boxes). 
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Polyamide conjugate specifically alkylates adenines adjacent to binding sites 
Upon heat-induced cleavage, all alkylation sites observed for conjugate 2 at 
subnanomolar concentrations were adjacent to target polyamide-binding sites (Figure 
6.7). Due to the symmetry of the 5' -WGCWGCW-3' binding site, the polyamide binds 
in two orientations, alkylating adenine residues adjacent on either side of the polyamide 
binding site (Figure 7.7B). At concentrations greater than 1 nM, minor cleavage was 
observed proximal to double base pair mismatch sites as well. Specificity for reaction at 
match sites over mismatch sites is approximately 20-fold. 
For the thermal cleavage assays, alkylation of adenine was observed at all but one 
interesting exception. The exception was cleavage of guanine at one of the mismatch 
sites. Reaction at N3 of guanines has previously been observed with tallimustine, a PY3 
conjugate with a bis(dichloroethylamino)benzene derivative (25, 26). 
Effects of Tether on Alkylation 
No alkylation was observed for benzoic acid mustard analogue 3 at concentrations 
up to 10 ~M. This suggests that the short, rigid carbamido linker prevents alkylation for 
two possible reasons: Either the linker points the alkylator into the minor groove, 
severely decreasing the binding affinity of the conjugate or the alkylator is merely 
restricted from being close enough to the N-3 of adenine to allow for covalent 
attachment. This contrasts the longer, more flexible C-4 linker of chlorambucil, which 








mismatch ~ mismatch 
TCCCCAGTCCCGCCCCAGGCCACGCCTCCCTGGAAAGTCCCCAGCGGAAAGTCCC~~~GCTCGATGT~GCA~ 
AGGGGTCAGGGCGGGGTCCGGTGCGGAGGGACCTTTCAGGGGTCGCCTTTCTGGG CGAGATACACGT 
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Figure 6.7. (a) Sequence of the 241 bp pHI V -LTR Eco RIIHind III restriction fragment. The five binding 
sites are indicated by boxes. Base pair mismatches are indicated by gray boxes. Cleavage sites of adenine-
or guanine-N3 lesions at 10 nM are indicated by arrows. Large and small arrows indicate major and minor 
alkylation sites, respectively. (b) Binding models for alkylation are shown. Models are colored as in Figure 
1. 
Alkylation of the exocyclic amine of guanine by polyamide conjugates 
When the thermal cleavage assays were carried out on the 5' -end labeled 
restriction fragment, a slower mobility fragment appears in the gel electrophoresis assay 
above the intact DNA indicating the presence of a stable adduct retarding the full-length 
fragment. The stability of the adduct to heat and piperidine workups suggested that the 
adduct was the result of alkylation of the exocyclic amine of guanine in the minor groove. 
To test this, inosine substitution at that position was employed. 
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Inosine which lacks the exocyclic NH2 of guanine was incorporated into a 120 
base pair fragment at the putative guanine reaction site located adjacent to the match site. 
The strands with inosine substitutions, as well as a strand with no inosine substitutions, 
were 5' end labeled and annealed to a complementary strand and thermal cleavage assays 
were performed (Figure 6.8). The results of the thermal cleavage assay of the 5' labeled 
synthetic oligonucleotides without inosine substitutions were identical to alkylation of the 
restriction fragment (Figure 6.8A). Substitution of the guanine in the sequence 5'-
AGCAGCTGCT-3' eliminated the anomalous band which results from the stable adduct 
(Figure 6.8B). Thus, certain DNA sequences allow the covalent reaction of the exocyclic 
amine of guanine by the polyamide-bis(dichloroethylamino)benzene conjugate. 
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Figure 6.8. Thermal cleavage assay experiments with ImPy-~-ImPy-(R)cHLy-ImPy-~-ImPy-~-Dp (2) on 5'-
32P-end-Iabeled 120 base pair oligonucleotides with and without inosine substitutions. (a-b) The solid 
arrows indicate cleavage bands from cleavage sites of adenine-N3 lesions on the restriction fragment. The 
hollow arrow indicates alkylation at the exocyclic amine of guanine. (a) The fragment contains the site 5'-
AGCAGCTGCT. Lane 1, A-specific reaction; lane 2, G-specific reaction; lanes 3-6, 100 pM, I nM, 10 
nM, respectively. (b) The fragments contain the site 5 5'- AICAGCTGCT -3'. Lanes 1-4, 100 pM, I nM, 
10 nM, respectively. (c) Model bound to match site 5'-AGCTGCT-3'. X indicates site of inosine 
substitution. Models are colored as in Figure I. 
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Time Dependence of Alkylation 
The half life for hydrolysis of the bis(dichloroethylamino)benzene moiety of 
chlorambucil in water at pH 7.5 and 37° C is approximately 1.3 hours (27). One would 
anticipate that at very low concentrations of polyamide conjugates there will be a 
competition between inactivation of the conjugate by hydrolysis and binding/covalent 
reaction with DNA. Therefore the time dependence of alkylation reactions with the 
polyamide conjugate 2 at a 0.5 nM concentration were monitored for 24 hours (pH 7.0, 
37° C) (Figure 6.9). Under these conditions, alkylation was half completed at match sites 
in 2.2 hours and the final cleavage yield on the bottom strand was 45%. Cleavage was 
detectable as early as 10 minutes and the yield did not increase after 24 hours. 
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Figure 6.9. Thermal cleavage assay experiments with ImPy-~­
ImPy-(RfHL.y-ImPy-~-ImPy-~-Dp (2) on the 3'-32P-end-Iabeled 
241 base pair EcoRIIHindIII restriction fragment from plasmid 
pHIV-LTR. Storage phosphor autodiogram of 8% denaturing 
polyacrylamide gels used to separate the fragments generated 
by heat induced DNA cleavage at alkylation sites. All 
reactions contained 10,000 cpm restriction fragment, 10 mM 
Tris·HCI (pH 7.0), 10 mM KCI, 10 mM MgCI2 and 5 mM 
CaClz and were performed at 37° C. Following equilibrations 
of 10 minutes-24 hours, the DNA pellet was resuspended in 
sodium citrate buffer (pH=7.2) and heated to 90° C for 15 min 
to thermally cleave at sites of adenine- or guanine-N3 lesions. 
Lane 1, intact DNA; lane 2, A-specific reaction; lane 3, G-
specific reaction; lanes 4-11, 500 pM ImPy-~-ImPy_(R)cHLy_ 
ImPy-~-lmPy-b-Dp (2), equilibrations for 10 min, 20 min, 30 
min, 1 h, 2 h, 4 h, 12 h, 24 h, respectively. Right. models 
bound to match sites on the DNA fragment. The polyamide is 
colored as in Figure 7. The solid arrows indicate cleavage 
bands from cleavage sites of adenine- or guanine-N3 lesions on 
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Figure 6.10. Alkylation by polyamide homodimer-chlorambucil conjugate. 
Subsequent to this initial study of chlorambucil-polyamide conjugates, several 
other hairpin conjugates have been synthesized (data not shown). Good alkylation yields 
were observed 1-2 bp adjacent to match sites, confirming the generality of this design for 
sequence specific alkylation. Chlorambucil has also been attached to other polyamide 
motifs, including tandems and homodimers. Conjugate 8 displayed particularly good 
specificity and yield of alkylation when targeted to its match site on a restriction 
fragment. Quantitative cleavage was observed at 3 nM and cleavage was only observed 
at the match sites on either strand at these concentrations. 
119 
Conclusion 
At subnanomolar concentrations the hairpin polyamide delivers the electrophilic 
bis(dichloroethylamino)benzene to the predetermined sequence and produces a specific 
covalent reaction in high yield in the minor groove of DNA. The attachment of the 
chlorambucil moiety at the y-tum results in no significant alteration of the polyamide-
DNA binding affinity. The parent eight-ring hairpin polyamide is cell permeable, and the 
next technical hurdle is to determine whether the new polyamide-
bis( dichloroethyl amino )benzene conjugates will also permeate eukaryotic cells. The 
parent hairpin polyamide 1 has been shown to inhibit HIV replication in cell culture, and 
this will form the basis of our next experiment. Conjugate 2 targeted to the same HIV-l 
promoter can now be tested in cell culture, to determine its ability to inhibit transcription. 
Further downstream this should set the stage for site-specific alkylation in "coding 
region" of genes in order to inhibit transcription during the elongation phase. Sequence-
specific DNA cleavage by multiple polyamide conjugates could provide a basis for 
"genetic microsurgery," whereby undesired gene segments or integrated viral DNAs 
could be selectively removed from a host genome in vivo. 
Experimental 
Materials 
IH NMR spectra were recorded on a General Electric-QE NMR spectrometer at 
300 MHz with chemical shifts reported in parts per million relative to residual solvent. 
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UV spectra were measured in water on a Hewlett-Packard Model 8452A diode array 
spectrometer. Matrix assisted, laser desorption/ionization time-of-flight mass 
spectrometry (MALD I-TO F) was performed at the Protein and Peptide Microanalytical 
Facility at the California Institute of Technology. HPLC analysis was performed using a 
Beckman Gold Nouveau system using a Rainen C18, Microsorb MV, 5 /-lm, 300 X 4.6 
mm reversed phase column on 0.1 % (wt/v) TFA with acetonitrile as eluent and a flow 
rate of 1.0 ml/min, gradient elution 1.25% acetonitrile/min. Preparatory reverse phase 
HPLC was performed on a Beckman HPLC with a Waters DeltaPak 25 X 100 mm, 
100-mm C18 column equipped with a guard, 0.1 % (wt/v) TFA, 0.25% acetonitrile/min. 
Water was obtained from a Millipore MilliQ water purification system, and all buffers 
were 0.2 /-lm filtered. Reagent-grade chemicals were used unless otherwise stated. 
Oligonucleotides were synthesized by the Caltech Biopolymer Synthesis and Analysis 
Resource Center. Restriction enzymes were purchased from either New England Biolabs 
or Boeringer-Mannhein and used accorded to the manufacturer's protocols. [a_32p]_ 
Thymidine-5' -triphosphate (~ 3000 Ci. mmol) and [a -32P]-deoxyadenosine-5'-
triphosphate (~ 6000 Ci. mmol) were purchased from DuPontlNEN. [y-32P]-Adenosine-
5' -triphosphate (~7000 Ci. mmol) was obtained from ICN. 
Synthesis of polyamide- bis( dichloroethylamino )benzene conjugates 
ImPy-Ji-ImPy-(R)H,Ny-ImPy-Ji-ImPy-Ji - Dp (6). I mPy -/3-ImPy-(R)H2Ny-ImPy-/3-
ImPy-/3-Pam-resin was synthesized in a stepwise fashion by Boc-chemistry manual solid 
phase protocols (21, 22). A sample of the resin was treated with neat (dimethylamino)-
propylamine (2 ml), heated (55 0 C, 48 hours) and purified by reversed phase HPLC. 
ImPy-/3-ImPy-(R)H2Ny-ImPy-/3-ImPy-/3-Dp was recovered as a white powder upon 
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lyophilization of the appropriate fraction (18 mg, 10.4% recovery). UV (H20) "'max (E), 
306 (69,500); IH NMR (DMSO-d6): 8 10.97 (s, 1 H), 10.39 (s, 1 H), 10.25 (s, IH), 10.00 
(s, IH), 9.97 (s, IH), 9.90 (s, IH), 9.24 (bs, 1 H), 8.15 (m, 5 H), 8.03 (bd, 3 H, J = 6.1 
Hz), 7.47 (s, IH), 7.42 (s, 1 H), 7.40 (s, 1 H), 7.35 (s, 1 H), 7.18 (m, 4 H), 7.01 (s, 1 H), 
6.97 (s, IH), 6.92 (s, 1 H), 6.90 (m, 2 H), 3.91 (m, 13 H), 3.75 (s, 12 H), 3.33 (m, 6 H), 
3.24 (m, 2 H), 3.06 (q, 2 H, J = 6.0), 2.95 (quintet, 2 H, J = 5.0),2.54 (t, 4 H, J = 6.8 Hz), 
2.30 (t, 2 H, J = 7.0), 1.94 (m, 2 H), 1.68 (quintet, 2 H, J = 7.3 Hz); MALDI-TOF-MS 
(monoisotopic) [M + H] 1381.6 (1381.6 calcd for C62HsIN26012). 
Impy-p-ImPy-(R)CHL'Y-Impy-p-ImPy-P-Dp (2). To a solution of chlorambucil (5.7 mg, 
Fluka) in 20 j..ll DMF was added DCC (7.7 mg) and HOBt (2.7 mg). The solution was 
stirred for 1 hour. The OBt ester solution was added to ImPy-~-ImPy-(R)H2Ny-ImPy-~­
ImPy-~-Dp (4 mg) in 400 j..ll DMF followed by 200 j..ll DIEA. The reaction mixture was 
stirred for 2 hours. TFA (150 j..ll) was added to the reaction mixture and the mixture was 
purified by reversed phase HPLC. ImPy-~-ImPy-(R)cHLy-ImPy-~-ImPy-~-Dp was 
recovered as a white powder upon lyophilization of the appropriate fraction (1 mg, 21 % 
recovery). UV (H20) "'max (E) 306 (69,500); IH NMR (DMSO-d6): 8 10.43 (s, 1H), 10.31 
(s, 1 H), 10.30 (s, 1 H), 10.25 (s, 1 H), 10.09 (s, 1 H), 9.96 (s, 1 H), 9.52 (s, 1 H), 8.09, 
(m, 8 H), 7.47 (s, 2 H), 7.45 (s, 1 H), 7.40 (s, 1 H), 7.25 (m, 4 H), 7.05 (s, 2 H), 7.02 (s, 1 
H), 6.96 (m, 4 H), 6.67 (s, 1 H), 6.64 (s, 1 H), 3.98 (s, 3 H), 3.95 (s, 6 H), 3.81 (s, 6 H), 
3.79 (s, 1 H), 3.69 (s, 6 H), 3.52 (M, 8 H), 3.12 (q, 2 H, J = 5.8 Hz), 3.01 (quintet, 2 H, J 
= 6.0 Hz), 2.75 (d, 6 H, J = 4.7 Hz), 2.61 (m, 4 H), 2.37 t, (t, J = 6.9 Hz), 2.03 (t, 6 H, J = 
6.9 Hz), 2.01 (m, 8 H), 1.74 (m, 4 H), 1.63 (m, 2 H), 1.47 (m, 2 H) ;MALDI-TOF-MS 
(monoisotopic) [M + H] 1666.7 (1666.7 calcd for C76H9sCl2N27013)· 
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ImPy-p-ImPy-(RfHL(OH)2y-Impy-p-ImPy-Ji -Dp (4). I mPy - Ji - ImPy - (R)CHLy_ ImPy-Ji-
ImPy-Ji-Dp (50 nmol) was dissolved in 0.1 NaOH (100 /-ll). After 4 hours, hydrolysis was 
determined complete by analytical HPLC. The solution was neutralized with ammonium 
acetate and concentrated in vacuo. 
Dp-CHL (5). To a solution of chlorambucil (304 mg) in 500 /-ll DMF was added DCC 
(208 mg) and HOBt (143 mg). The solution was stirred for 1 hour. The OBt ester 
solution was added to (dimethylamino)-propylamine (63 /-ll) in 500 ml DMF followed by 
500 /-ll DIEA. The reaction mixture was stirred for 2 hours. TFA (0.01 % (wtJv), 6 ml) 
was added to the reaction mixture and the mixture was purified by reversed phase HPLC. 
Dp-CHL is recovered as a yellow oil upon lyophilization of the appropriate fraction (50 
mg, 12.9% recovery). MALDI-TOF-MS (monoisotopic) [M + H] 388.4 (388.4 calcd for 
C19H31C12N30). 
Preparation of 3'- or 5,-32P-Iabeled DNA restriction fragment 
Plasmid pHIV-LTR (23)was digested with EcoRI, labeled at either the 3' or 5' 
end and digested with HindIII. The 241 base pair restriction fragment was isolated by 
nondenaturing gel electrophoresis. Chemical sequencing reactions were performed as 
described (28, 29). Standard techniques were employed for DNA manipulation (30). 
Detection of heat-induced single-strand DNA cleavage 
All reactions were executed in a total volume of 40 ml. A polyamide stock 
solution or H20 was added to an assay buffer containing radiolabeled restriction fragment 
(10,000 cpm), affording final solution conditions of 10 mM TriseHCl, 10 mM KCI, 10 
mM MgCI2, 5 mM CaCI2, pH 7.0, and either 1 pM-lO nM nitrogen mustard-polyamide 
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conjugate or no conjugate (for reference lanes). The solutions were equilibrated at 37° C 
for the desired time period. The reactions were stopped by the addition of 60 ml of a 
solution containing 0.6 M NaOAc, 12.5 mM EDTA, 0.15 mM (bp) calf thymus DNA, 
2.0 M NaCI, 0.8 mg/ml glycogen, and ethanol precipitated. Reactions were resuspended 
in 40 milO nM sodium citrate buffer, pH 7.2, and heated for 30 minutes at 95° C. The 
reactions were ethanol precipitated and resuspended in IX TBE/80% formamide loading 
buffer, denatured by heating at 85° C for 10 min, and placed on ice. The reaction 
products were separated by electrophoresis on an 8% polyacrylamide gel (5% cross-link, 
7 M urea) in IX TBE at 2000 V. Gels were dried and exposed to a storage phosphor 
screen (Molecular Dynamics)(3J). 
Quantitative DNase J footprint titration experiments 
All reactions were executed in a total volume of 400 ml. A polyamide stock solution or 
H20 (for reference lanes) was added to an assay buffer containing radiolabeled restriction 
fragment (20,000 cpm) affording final solution conditions of 10 mM TriseHCI, 10 mM 
KCI, 10 mM MgCI2, 5 mM CaCI2, pH 7.0, and either I pM-I0 nM nitrogen mustard-
polyamide conjugate or no conjugate (for reference lanes). The solutions were allowed to 
equilibrate at 22° C for 18 hours. Footprinting reactions were initiated by the addition of 
4 ml of a DNase I stock solution (at the appropriate concentration to give about 55% 
intact DNA) containing I mM DTT and allowed to proceed for 7 min at 22° C. The 
reactions were stopped by the addition of 50 ml of a solution containing 1.25 M NaCI, 
100 mM EDTA, 0.2 mg/ml glycogen, and 28 mM (bp) calf thymus DNA, and ethanol 
precipitated. Reactions were resuspended in 1 X TBE/80% formamide loading buffer, 
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denatured by heating at 85° C for 10 min, and placed on ice. The reaction products were 
separated by electrophoresis on an 8% polyacrylamide gel (5% cross link, 7M urea) in 1 
X TBE at 2000 V for 1.5 h. Gels were dried and exposed to a storage phosphor screen 
(Molecular Dynamics). 
Quantitation and data analysis 
Data from the footprint titration gels were obtained using a Molecular Dynamics 400S 
Phosphor1mager followed by quantitation using 1mageQuant software (Molecular 
Dynamics). Background-corrected volume integration of rectangles encompassing the 
footprint sites and a reference site at which DNase I reactivity was invariant across the 
titration generated values for the site intensities (I. ) and the reference intensity (I ). 
site ref 
The apparent fractional occupancy (8app) of the sites were calculated using the following 
equation: 
8app = 1 - 1site/Iref 
1siteO /1refo 
(1) 
where 1°. and 1° are the site and reference intensities, respectively, from a control lane 
SIte ref 
to which no polyamide was added. The ([L]tot' 8app) data points were fit to a Langmuir 
binding isotherm (eq 2, n= I) by minimizing the difference between 8app and 8 ftI' using the 
modified Hill equation: 
(2) 
where [L] is the total polyamide concentration, Ka is the equilibrium association 
tot 
constant, and 8min and 8max are the experimentally determined site saturation values when 
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the site is unoccupied or saturated, respectively. The data were fit using a nonlinear 
least-squares fitting procedure with Ka, 8max, and 8min as the adjustable parameters. All 
acceptable fits had a correlation coefficient of R > 0.97. Five sets of data were used in 
determining each association constant. All lanes from each gel were used unless visual 
inspection revealed a data point to be obviously flawed relative to neighboring points. 
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CHAPTER 7 




The combination of DNA binding pyrrole/imidazole polyamides with nonspecific 
alkylator, chlorambucil, creates a class of sequence-specific DNA alkylating compounds. 
Since the compounds exhibit good specificity and yield of DNA alkylation, we 
investigated their activity in biological systems. A chlorambucil-polyamide conjugate 
displays enhanced in vitro cross-linking, alkylation and inhibition of replication of SV40 
DNA when compared to unmodified chlorambucil. Additionally, the compound is shown 
to alkyl ate its target site in a HIV promoter DNA sequence that has been integrated into 
genomic DNA in cells and in cell free conditions. A dye labeled derivative showed 
increased nuclear localization in three cell types relative to a dye-labeled polyamide with 
the alkylator moiety when examined by confocal microscopy. Most interestingly, the 
conjugate showed markedly different toxicity for several cell lines. The evidence of 
nuclear localization further supports the proposed mechanism of gene regulation of 




A general method for specifically and efficiently alkylating and cutting 
predetermined DNA sequences with cell permeable molecules could be a useful tool for 
regulation of gene expression. An initial step toward this goal has been made by the 
creation of a class of molecules combining pyrrole/imidazole polyamides which bind 
predetermined DNA sequences with high affinity and specificity with the well-
characterized DNA alkylator, chlorambucil (CHL) (1). Bis (dichloroethylamino) benzene 
derivatives were attached to the y-tum of an eight-ring hairpin polyamide targeted to the 
HIV promote and found to bind and selectively alkylate the desired target sites in the 
HIV promoter at subnanomolar concentrations. Since the chlorambucil-polyamide 
conjugates demonstrated that DNA damage could be targeted to specific DNA sequences 
by polyamides, we were interested in further investigating the DNA interactions and 
biological activities of this class of compounds. 
We describe here several studies of the biological activity of polyamide-
chlorambucil conjugate 1. First data will be presented on in vitro cross-linking, alkylation 
and replication of SV40 DNA by compound 1 and unmodified chlorambucil. Next, in 
vitro vs. in vivo alkylation by compound 1 of a stably integrated HIV promoter will be 
compared. The toxicity of the compound will also be investigated in several cell lines. 
Finally, cell trafficking of a BODIPY -dye-polyamide conjugate studied by confocal 
microscopy will be examined. 
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Figure 7.1. Structures of poly ami des 1-3 and chlorambucil 4. 
Results and Discussion 
Induction of DNA interstrand cross-links in vitro 
132 
Methods used for the detection of DNA interstrand cross-links often involve the 
use of harsh procedures (high temperature or alkali) to separate single strands in linear 
plasmid DNA. As the stability of the chlorambucil-induced DNA alkylations/cross-links 
could be compromised under such conditions, we employed a "mild" methods based on 
133 
heating the linear DNA in 65% formamide to 55° C for 10 min. under these conditions 
the control DNA denatured and unstable cross-links were reasonably conserved (2). 
The dependence of NW-l-induced DNA cross-linking on incubation time was 
investigated by treating linear SV40 DNA with 10 /-lM drug for up to 4 h before ethanol 
precipitation and gel analysis of cross-link formation. As shown in Figure 7.2, a level of 
cross-links increased rapidly up to -1 h, and after which began to plateau and the damage 
to DNA (low molecular "smear") started to prevail (data not shown). Thus, 1 h 
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Figure 7.2. (A) Time dependence of DNA interstrand cross-link induction by chlorambucil polyamide 
conjugate 1. SV40 DNA was incubated with 10 f.lM 1, purified and resolved on agarose gels. (B) 
Concentration dependence of cross-link induction in I hour, with CHL and polyamide 2 as controls. 
Once the treatment time had been selected, the concentration dependence of 
interstrand cross-linking was studied. Linear SV40 DNA was treated for 1 h with 0.1, 1 
and 10 /-lM NW-l, then purified and analyzed on agarose gel. As shown in Figure XB, 
DNA treated with drug showed a concentration-dependent increase in DNA migration. At 
10 /-lM, -75% of total DNA was cross-linked. The ability of NW-l and its parent 
compounds (NW-2 and CHL) to induce DNA interstrand cross-links and/or alkylation in 
isolated DNA was compared using the conditions established above (1 h treatment with 
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up to 10 ~M drug). The results clearly show that NW-l is more efficient than freely-
diffusing chlorambucil. Additionally, the polyamide compound lacking the alkylator was 
unable to preserve double-strand DNA under the employed "mild" denaturing conditions, 
thus excluding possibility of creating noncovalent "virtual" cross-links. It should be noted 
for this experiment and ensuing experiments that the half-life of DNA alkylation by 
polyamide 1 is - 5 h (1). Although the short incubation times (1 h) are sometimes 
necessary due to instability of the systems, the results of these studies are not a true 
reflection of the potency of the compound. Efficient alkylation and cross-linking likely 
occurs at lower concentrations and higher yields at 12 h equilibration times. 
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Figure 7.3. Comparison of in vitro SV40 DNA and SV40 minichromosomes alkylation and cross-linking 
by polyamides 1 and 2 and ChI after 1 h drug treatment. (A) Alkylation of SV40 DNA after 1 h treatment 
with 0.1, 1 and 10 11M of ChI, 1 and 2. (B) Alkylation of SV40 minichromosomal DNA after I h treatment 
with poly ami des 1 and 2 and ChI. SV40 DNA was drug-treated, purified, then resuspended in TE and 
heated at 70° C for 2 h to convert DNA alkylation lesions to strand breaks. 
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The drug-induced DNA alkylations were converted to DNA strands by heating at 
70° C for 2 h (Figure 7.3). Both plasmid SV40 DNA and minichromosomal SV40 DNA 
were treated with the studied compounds (3-5), allowing a comparison between the 
drug's action upon "naked" and protein protected DNA. The damage observed of plasmid 
and minichromosomal DNA was similar. NW-l could efficiently alkyl ate DNA at 
concentration ~ 10 IlM, whereas the not cleavage was observed with CHL. 
Inhibition of SV 40 DNA replication in cell-free in vitro system 
SV40 DNA replication was used to examine the functional effects of NW-l-
induced DNA modifications (6). DNA was incubated with the compound at 3 and 0.3 IlM 
concentrations, and then extensively purified, completely losing its replication template 
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Figure 7.4. Polyamide 1 induced inhibition of SV40 DNA replication in cell-free system using drug-treated 
DNA template. Reaction mixtures containing 30 Ilg of cell extracts, 50 ng of SV40 DNA template and 0.6 
Ilg of SV40 T-antigen were incubated at 37° C for I h. Replication products were isolated, resolved on 
0.8% neutral agarose gels (A), visualized by autoradiography, analyzed and quantitated (B). Positions of 
plasmid form I, II and replication intermediates (RI) are indicated. 
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In Vitro vs. In Vivo Alkylation of Genomic DNA 
One criticism of the observed inhibition of HIV -1 transcription by hairpin 
polyamides (7) is that inhibition in cells was inferred from viral replication rather than 
from direct transcript levels. Potentially polyamides affect replication by downregulation 
of other genes or interruption of another cellular process. Alkylation by a chlorambucil-
polyamide conjugate provides a direct chemical readout that demonstrates that the ligand 
can traffic through the cell membrane, into the nucleus, and binds the desired target 
sequence. CEM cells with a stably integrated HIV -1 promoter attached to a GFP reporter 
gene were treated with 500 nM of 1 or control 3 for 24 h. Following isolation of the 
genomic DNA and heat induced cleavage by piperidine, cleaved DNA in the HIV 
promoter region was amplified by ligation-mediated PCR with a P-32 labeled primer. For 
comparison, genomic DNA was treated with either of the compounds and worked up 
identically. No alkylation was observed in either case when cells or DNA were treated for 
only I h and worked up. The fragments were separated on a sequencing gel for analysis. 
Alkylation was observed at match sites adjacent to the TAT A Box and ETS sites, 
as well as at a mismatch site (see Figure 7.5). This compares favorably to alkylation sites 
observed on a restriction fragment that contained the same HIV promoter DNA sequence. 
Alkylation yields were much lower, though, since significant cleavage was observed at 
low nanomolar concentrations under optimized in vitro conditions on a 241 bp restriction 
fragment (1). Higher concentrations and lower alkylation efficiency are expected, though, 
since many other match sites are present in the genomic DNA. More importantly, the 
roughly equal alkylation of the match site, whether the genomic DNA is in the nucleus 
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Figure 7.5. Comparison of in vitro and in vivo alkylation by chlorambucil-polyamide conjugate L For in 
vivo results. CEM cells were treated with 500 nM of 1 overnight. The genomic DNA was isolated, treated 
with piperidine and heated to induced DNA strand cleavage. The cleaved DNA was amplified by 
ligation-mediated PCR. Storage phosphor autoradiograms: (A) Coding strand for the TAT A box. (B) Non-
coding strand for the Ets-I site. Alkylation sites are shown to the right of the gels. 
or in solution, potentially shows that the polyamide can traffic into the nucleus and bind 
it's designed target site in the nucleus. 
A Survey of Cellular Growth Inhibition 
Since researchers in the Baltimore and Beerman groups had observed different 
toxicities used polyamide-chlorambucil conjugates (toxic at 10 nM in 293T cells and not 
toxic in BSC-l cells, respectively), it seemed prudent to look at a panel of cell lines to 
scan for biological activity. Interestingly, NW -1 has vastly different toxicity profiles for 
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different cell lines ranging from inhibition of cell growth at low nanomolar 
concentrations to no observed effects of growth at concentrations of 2 ~M. The 
compound demonstrated highest toxicity to T -cells, which correlates well with success at 
inhibition of transcription by hairpin polyamides in T-cells. Like most alkylating agents 
NW-l was observed to block cells in 02 phase, resulting in the observed inhibition of 
cell growth. 
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Figure 7.6. Inhibition of cell growth after treatment for 4 days with compounds 1 and 2 and ChI. 
Table 7.1. Cell lines sensitive to NW-l (lCso < 1000 nM) 
Cell Line Cell line description IC50 (nM) 
lurkat Human R cell leukemia (suspension) -2.2 
293 Human transformed embryonic kidney cells -15 
H460 Human non-small-celliung carcinoma (NSCLC) -18.6 
Hela S3 Human epitheloid carcinoma -200 
A2780-DX5 Ovarian cancer cells - resistant -737 
Table 7.2. Cell lines NOT sensitive to NW-l (IC50 > 2000 nM) 
Cell line Cell line description 
BSC-l African green monkey kidney cells 
HCT-116 Human colon carcinoma 
LCC6-MDR Breast Cancer cells - resistant 
DLD-l Human colon carcinoma 




HN ~ 0 ~ / 
( N~l. 0 0 H H II N N N N N~N 0 I 
o T ~ .~ H H ~ Jl .N 
N· I( QyH H N· \I) 
I 0 1~ N N H N 
N ~ {,-N H 
I 0 0 i!. ~ ,N 
NlfhH HI 
I 0 '~\('I(N~N~N ...... 
I 0 0 
6 
Figure 7.7. Structures of BODIPY labeled polyamides for cell permeability studies. 
Cell Permeability by a Chlorambucil-BODIPY -polyamide conjugate 
After initial successes of gene downregulating in cells with hairpin polyamides, it 
was observed that in several cases polyamides were successful in inhibiting transcription 
of a specific gene in vitro but was unsuccessful when tested in cells. While other 
explanations are possible, such as lack of specificity in a genomic DNA context, we 
speculated that lack of inhibition in a cellular system may be due to polyamides not 
trafficking to the nucleus. In order to investigate this hypothesis, a series of polyamide 
dye conjugates was synthesized and their cell trafficking properties were investigated by 
confocal microscopy. When polyamide-dye conjugates were added to the cell media, the 
ligands were observed in the nucleus in only a few cell types. When comparing the 
toxicity of chlorambucil-polyamide conjugates to the cell permeability data with 
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Figure 7.8. Synthesis of dye-alkylator-polyamide conjugate 6, 
are extremely toxic, yet a dye conjugate of the same parent polyamide is observed not to 
localize in the nucleus. In light of the conflicting data a chlorambucil-BODIPY-
polyamide conjugate was synthesized to investigate whether the chlorambucil moiety 
would alter cell trafficking properties, 
After synthesis of the polyamide by previously reported solid phase synthesis 
methods with Boc-protected monomers (8), the Fmoc protecting group on the DABA 
amine was deprotected with piperidine and replaced with a Boc group with Boc 
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anhydride. Cleavage from resin with the triamine and purification by prep HPLC provide 
compound 7 for conjugation. Coupling of S-trityl-p-propionic acid followed by 
deprotection of the trityl group and purification by Sep-Pak produced compound 9 
suitably functionalized for a one-pot addition of BODIPY and chlorambucil. A slight 
excess of BODIPY -maleimide was addition to 9 with 0.5 eq of DIEA. Excess maleimide 
was removed from the reaction mixture with a thiol scavenger resin followed by filtering 
off the resin. An excess DCC, HOBt activitated chlorambucil was added and the resulting 
product was purified by preparatory HPLC. Identity and purity of all compounds were 
determined by HPLC and MALDI-TOF mass spectrometry (Figure 7.8). 
Several cell lines were treated with 5 /-lM of compounds 5 and 6 and incubated 
overnight. Cell death of the dye-chlorambucil-polyamide conjugate was not observed at 
these concentrations, likely because the conjugation of the dye decreases DNA binding 
affinity and therefore alkylating potency. Examination of the cells by confocal 
microscopy revealed that addition of chlorambucil did not improve nuclear localization 
except in a few cases (Figure 7.9). Most notably polyamide 6 was localized in the nucleus 
in NB4 cells, whereas compound 5 was only observed in the cytoplasm. Nuclear 
localization in CEM cells and primary T -cells was also significantly increased for 
compound 6. Surprisingly, the alkylator was not observed in the nucleus in 293T cells, in 
which compound 1 showed low nanomolar toxicity. One can postulate that this 
discrepancy occurs because the dye alters nuclear localization or that toxicity is due a 
mechanism that does not involve DNA. Alternatively, the amount of alkylator in the 
nucleus necessary for inhibition of cell growth could be too low to be observed by 
confocal microscopy. 
142 
CEM (CCL) Cells with 5 CEM (CCL) with 6 
Human Primary T-Cells with 5 Human Primary T-Cells with 6 
NBR Cells with 5 NBR Cells with 6 
Figure 7.9. Imaging cell trafficking of polyamide dye conjugates by confocal microscopy. (upper left) 
Fluorescent image (upper right) bright field image (bottom left) merged images (bottom right) Dead cells 
stained with Sytox Orange. 
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Conclusion 
The variable toxicity to cells is likely the results of several factors. The 
differential cell uptake by polyamide-dye conjugates points to the obvious possibility that 
the polyamide-alkylators have different cell trafficking properties for each of the cell 
lines. With the current data, though, it must be considered that some cell lines may be 
more sensitive to DNA damage. Studies in recent years have demonstrated that cell lines 
have different thresholds of apoptosis. An additional consideration is that certain cell 
lines are able to more efficiently repair DNA damage induced by the alkylators. The 
sequence selectivity of the polyamide may target DNA sequences that are more vital to 
the sensitive cell lines. While there is no definitive answer at this time to explain the 
efficacy of the alkylator, the observed pharmacological properties of this new class of 
compounds represent a beginning of line of scientific inquiry. As polyamides with higher 
specificity for DNA within a genomic context are developed, alkylator polyamide 
conjugates may provide a means for "genetic microsurgery," whereby undesired gene 
segments or integrated viral DNAs could be removed from a host genome in vivo. At a 
minimum these results provide a clue that may lead future investigators to modify 
polyamides in such a way to improve cell-tracking properties, perhaps even grant cell-
type specific nuclear localization. 
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Experimental 
ImPy-fi-ImPy-(R)NHBocy-ImPy-fi-ImPy-fi -Trit (7) ImPy-[3-ImPy-(R)NHFmocy-ImPy_[3_ 
ImPy-[3-PAM Resin was synthesized in a stepwise fashion manual solid phase methods 
from Boc-[3-PAM resin (600 mg, 0.75 mmollg). A portion of the resin (200 mg) was 
de protected with 20% piperidine in DMF. The amine was reprotected with Boc20 and 
DIEA. The resin was washed, dried, and treated with 3,3' -diamino-N-
methyldipropylamine for 12 hours at 60° C. Purification as previously reported yielded 
Impy-[3-ImPY-(R)NHBocy-ImPy-[3-ImPy-[3-Tr 7 (28 /-lmol, 18.6% recovery). UV (H20) Amax 
310 (68,000) MS (MALDI-TOF): [M+Ht 1524.8 (C69H76N200]]+, [M+Ht, calc. 1524.7) 
ImPy-fi-ImPy-(RtHBOCy-ImPy-fi-ImPy-fi-Tr-fi-SHTrit (8) S-trityl-[3-propionic acid 
(35 mg, 100 /-lmol) and HBTU (38 mg, 100 /-lmol) were dissolved in DMF (100 /-ll) 
followed by addition of DIEA (50 /-ll). After 15 minutes, 10 /-l1 of the activated acid was 
added to polyamide 7, dissolved in DMF (200 /-ll). After 1 hour and room temperature, 
the reaction was determined complete by analytical HLPC. The product was purified on a 
C8 Sep-Pak cartridge (2 g) with acetonitrile and 0.1 % aqueous TF A. Pure fractions were 
identified by analytical HPLC and lyophilized to give a white solid (3.2 /-lmol). UV (H20) 
Amax 310 (68,000) MS (MALDI-TOF): [M+Ht 1854.9 (C91Hll2N2701/' [M+H]+, calc. 
1855.0). 
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ImPy-~-ImPy-(R)NH2'Y-ImPy-~-ImPy-~-Tr-~-SH (9) Polyamide 8 (3.2 f.lmol) was 
dissolved in neat TFA (100 f.ll). After 5 minutes triethyl silane was added to the bright 
yellow solution until the color dissipated (-20 f.ll). TF A was removed in vacuo, the 
residue was dissolved in 20% acetonitrile/80% 0.1 % TFA, and the product was purified 
on a C8 Sep-Pak cartridge (2 g) with acetonitrile and 0.1 % aqueous TFA. Pure fractions 
were identified by analytical HPLC and lyophilized to give a white solid (2.4 f.lmol). UV 
(H20) Amax 310 (68,000) MS (MALDI-TOF): [M+Ht 1512.7 (C67H90N27013+' [M+Ht, 
calc. 1512.8). 
Polyamide (6). BODIPY -maleimide (2.6 f.lmol in 20 f.ll of DMF) was added to a solution 
of polyamide 9 (2.4 f.lmol) dissolved in DMF (200 f.ll) followed by addition of DIEA (2 
f.ll). After the reaction was judged complete by analytical HPLC, thiol scavenger resin (20 
mg) was added. In a separate tube, chlorambucil (46 mg), DCC (31 mg) and HOBT (22 
mg) were dissolved in DMF. After 30 minute the resin was filtered off and 20 f.ll of the 
activated chlorambucil solution was added to the polyamide-dye solution. The reaction 
mixture was mixed at room temperature for 1 hour and then preparatory reverse phase 
HPLC afforded polyamide 6 upon lyophilization of the appropriate fractions (900 nmol 
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